<SEC-DOCUMENT>0001628280-24-050056.txt : 20241205
<SEC-HEADER>0001628280-24-050056.hdr.sgml : 20241205
<ACCEPTANCE-DATETIME>20241205160217
ACCESSION NUMBER:		0001628280-24-050056
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20241204
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241205
DATE AS OF CHANGE:		20241205

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			agilon health, inc.
		CENTRAL INDEX KEY:			0001831097
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				371915147
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40332
		FILM NUMBER:		241529069

	BUSINESS ADDRESS:	
		STREET 1:		6210 E HWY 290
		STREET 2:		SUITE 450
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78723
		BUSINESS PHONE:		562-256-3800

	MAIL ADDRESS:	
		STREET 1:		6210 E HWY 290
		STREET 2:		SUITE 450
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78723

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Agilon Health Topco, Inc.
		DATE OF NAME CHANGE:	20201103
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>agl-20241204.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:17fb4859-5918-4cfb-84e0-0b572b54c452,g:8a35e750-400b-4819-bea7-8c5b4698656a,d:9f0d0660849a414d81bfd54e2b7eacfa-->
<html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>agl-20241204</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-27">0001831097</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-28">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="agl-20241204.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001831097</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-04</xbrli:startDate><xbrli:endDate>2024-12-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001831097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:FormerAddressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-04</xbrli:startDate><xbrli:endDate>2024-12-04</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i9f0d0660849a414d81bfd54e2b7eacfa_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________________________________</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________________________________</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">December 4, 2024</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________________________________</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">agilon health, inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Exact name of Registrant as Specified in Its Charter)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________________________________</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.778%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.780%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-40332</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">37-1915147</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(State or Other Jurisdiction</span></div><div style="margin-top:0.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">of Incorporation)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Commission File Number)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(IRS Employer</span></div><div style="margin-top:0.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Identification No.)</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">440 Polaris Parkway</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-8">Suite 550</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-9">Westerville</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-10">OH</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-11">43082</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Address of Principal Executive Offices)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Zip Code)</span></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s Telephone Number, Including Area Code:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-12">562</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-13">256-3800</ix:nonNumeric></span></div><div style="margin-top:20pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-2" name="dei:EntityAddressAddressLine1" id="f-14">6210 E. Hwy 290</ix:nonNumeric>, <ix:nonNumeric contextRef="c-2" name="dei:EntityAddressAddressLine2" id="f-15">Suite 450</ix:nonNumeric>, <ix:nonNumeric contextRef="c-2" name="dei:EntityAddressCityOrTown" id="f-16">Austin</ix:nonNumeric>,  <ix:nonNumeric contextRef="c-2" name="dei:EntityAddressStateOrProvince" id="f-17">TX</ix:nonNumeric> <ix:nonNumeric contextRef="c-2" name="dei:EntityAddressPostalZipCode" id="f-18">78723</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Former Name or Former Address, if Changed Since Last Report)</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________________________________</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:1.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.870%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-19">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-20">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-21">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-22">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:38.295%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Title of each class</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trading</span></div><div style="margin-top:0.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Symbol(s)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Name of each exchange on which registered</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-23">Common stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-24">AGL</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-25">The New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8239;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8239;240.12b-2 of this chapter). </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-26">o</ix:nonNumeric></span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i9f0d0660849a414d81bfd54e2b7eacfa_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 1.01 Entry Into a Material Definitive Agreement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 4, 2024, agilon health, inc. (the &#8220;Company&#8221;) began entering into new forms of indemnification agreements with the Company&#8217;s directors, executive officers, and certain other officers (each, an &#8220;Indemnitee&#8221;). The indemnification agreements provide, among other things, that, subject to certain exclusions, the Company will indemnify an Indemnitee to the fullest extent permitted by applicable law and the Company&#8217;s Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws against all expenses actually and reasonably incurred and advance expenses on behalf of Indemnitee. Additionally, the new forms clarify the scope of the Company&#8217;s indemnification obligations and an Indemnitee&#8217;s rights. The indemnification agreements also establish various related procedures, processes and requirements. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each new indemnification agreement with a current director or officer will replace and supersede any prior indemnification agreement between the Company and such director or officer, if such director or officer was a party to a prior indemnification agreement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing summary description of the indemnification agreements is not intended to be complete and is qualified in its entirety by the complete text of the form indemnification agreements filed as Exhibit 10.1 and Exhibit 10.2 to this Form 8-K and incorporated herein by reference.</span></div><div id="i9f0d0660849a414d81bfd54e2b7eacfa_80"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8.01 Other Events.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 5, 2024,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company changed its principal executive offices from 6210 E. Highway 290, Austin, TX 78723 to 440 Polaris Parkway, Suite 550, Westerville, OH 43082. The Company's telephone number remains the same: (562) 256-3800.</span></div><div id="i9f0d0660849a414d81bfd54e2b7eacfa_10"></div><div style="-sec-extract:summary;margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01 Financial Statements and Exhibits.</span></div><div style="margin-top:6pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.84pt">Exhibits</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:88.143%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit</span></div><div style="margin-top:0.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.72pt"><span style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="ex-101indemnificationagree.htm">Form of Indemnification Agreement &#8212; Directors</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="ex-102indemnificationagree.htm">Form of Indemnification Agreement &#8212; Officers</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i9f0d0660849a414d81bfd54e2b7eacfa_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.356%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">agilon health, inc.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 5, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By: </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ JEFFREY SCHWANEKE</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jeffrey Schwanke<br/>Chief Financial Officer</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex-101indemnificationagree.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ib7629592906b4c6e88a32b2e8021029c_1"></div><div style="min-height:99.36pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Exhibit 10.1</font></div><div><font><br></font></div></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">INDEMNIFICATION AGREEMENT </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Indemnification Agreement (&#8220;Agreement&#8221;) is made as of ______________, 2024 by and between agilon health, inc., a Delaware corporation (the &#8220;Company&#8221;), and &#91;Board Director Name&#93; (&#34;Indemnitee&#34;).  This Agreement supersedes and replaces any and all previous Agreements between the Company and Indemnitee covering the subject matter of this Agreement.   </font></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">RECITALS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, each Amended and Restated Certificate of Incorporation of the Company (the &#8220;Certificate of Incorporation&#8221;) and the Amended and Restated Bylaws of the Company (the &#8220;Bylaws&#8221;, and together with the Certificate of Incorporation, the &#8220;Charter&#8221;) require indemnification of the directors of the Company.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, Indemnitee may also be entitled to indemnification pursuant to the General Corporation Law of the State of Delaware (the &#8220;DGCL&#8221;).  The Charter and the DGCL expressly provide that the indemnification provisions set forth therein are not exclusive, and thereby contemplate that contracts may be entered into between the Company and members of the board of directors, officers and other persons with respect to indemnification&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, it is reasonable, prudent and necessary for the Company contractually to obligate itself to indemnify, and to advance expenses on behalf of, such persons to the fullest extent permitted by applicable law so that they may serve or continue to serve the Company free from undue concern that they will not be so indemnified&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, this Agreement is a supplement to and in furtherance of the Charter and any resolutions adopted pursuant thereto, as well as any rights of Indemnitees under any directors&#8217; and officers&#8217; liability insurance policy, and this Agreement shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">NOW, THEREFORE, in consideration of the premises and the covenants contained herein, the Company and Indemnitee do hereby covenant and agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Services to the Company.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  Indemnitee has agreed to serve as a director of the Board of the Company.  Indemnitee may at any time and for any reason resign from such position (subject to any other contractual obligation or any obligation imposed by operation of law), in which event the Company shall have no obligation under this Agreement to continue Indemnitee in such position.  This Agreement shall not be deemed an employment contract between the Company (or any of its subsidiaries or any Enterprise) and Indemnitee.  Indemnitee specifically acknowledges that Indemnitee's employment with the Company (or any of its subsidiaries or any Enterprise), if any, is at will, and the Indemnitee may be discharged at any time for any reason, with or without cause, except as may be otherwise provided in any written employment contract between Indemnitee and the Company (or any of its subsidiaries or any </font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:99.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Enterprise), other applicable formal severance policies duly adopted by the Board, or, with respect to service as a director or officer of the Company, by the Charter and the DGCL.  The foregoing notwithstanding, this Agreement shall continue in force after Indemnitee has ceased to serve as a director of the Company, as provided in Section 16 hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Definitions.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  As used in this Agreement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">References to &#8220;agent&#8221; shall mean any person who is or was a director, officer, or employee of the Company or a subsidiary of the Company or other person authorized by the Company to act for the Company, to include such person serving in such capacity as a director, officer, employee, fiduciary or other official of another corporation, partnership, limited liability company, joint venture, trust or other enterprise at the request of, for the convenience of, or to represent the interests of the Company or a subsidiary of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">A &#8220;Change in Control&#8221; shall be deemed to occur upon the earliest to occur after the date of this Agreement of any of the following events&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.67pt">Acquisition of Stock by Third Party.  Any Person (as defined below) is or becomes the Beneficial Owner (as defined below), directly or indirectly, of securities of the Company representing fifty (50) percent  or more of the combined voting power of the Company's then outstanding securities unless the change in relative Beneficial Ownership of the Company's securities by any Person results solely from a reduction in the aggregate number of outstanding shares of securities entitled to vote generally in the election of directors&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.34pt">Change in Board of Directors.  During any period of two (2) consecutive years (not including any period prior to the execution of this Agreement), individuals who at the beginning of such period constitute the Board, and any new director (other than a director designated by a person who has entered into an agreement with the Company to effect a transaction described in Sections 2(b)(i), 2(b)(iii) or 2(b)(iv)) whose election by the Board or nomination for election by the Company's stockholders was approved by a vote of at least two-thirds of the directors then still in office who either were directors at the beginning of the period or whose election or nomination for election was previously so approved, cease for any reason to constitute at least a majority of the members of the Board&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.01pt">Corporate Transactions.  The effective date of a merger or consolidation of the Company with any other entity, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior to such merger or consolidation continuing to represent (either by remaining outstanding or by being converted into voting securities of the Surviving Entity) more than 50% of the combined voting power of the voting securities of the Surviving Entity outstanding immediately after such merger or consolidation and with the power to elect at least a majority of the board of directors or other governing body of such Surviving Entity&#59;</font></div><div style="margin-bottom:18pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.67pt">Liquidation.  The approval by the stockholders of the Company of a complete liquidation of the Company or an agreement for the sale or disposition by the Company of all or substantially all of the Company's assets&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Other Events.  There occurs any other event of a nature that would be required to be reported in response to Item 6(e) of Schedule 14A of Regulation 14A (or a response to any similar item on any similar schedule or form) promulgated under the Exchange </font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:99.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Act (as defined below), whether or not the Company is then subject to such reporting requirement.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes of this Section 2(b), the following terms shall have the following meanings&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;padding-right:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;&#8220;Exchange Act&#8221; shall mean the Securities Exchange Act of 1934, as amended from time to time.</font></div><div style="margin-bottom:12pt;padding-left:72pt;padding-right:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;&#8220;Person&#8221; shall have the meaning as set forth in Sections 13(d) and 14(d) of the Exchange Act&#59; provided, however, that Person shall exclude (i) the Company, (ii) any trustee or other fiduciary holding securities under an employee benefit plan of the Company, and (iii) any entity owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of stock of the Company.  </font></div><div style="margin-bottom:12pt;padding-left:72pt;padding-right:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;&#8220;Beneficial Owner&#8221; shall have the meaning given to such term in Rule 13d-3 under the Exchange Act&#59; provided, however, that Beneficial Owner shall exclude any Person otherwise becoming a Beneficial Owner by reason of the stockholders of the Company approving a merger of the Company with another entity.</font></div><div style="margin-bottom:18pt;padding-left:72pt;padding-right:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;&#8220;Surviving Entity&#8221; shall mean the surviving entity in a merger or consolidation or any entity that controls, directly or indirectly, such surviving entity.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">&#8220;Corporate Status&#8221; describes the status of a person who is or was a director, trustee, partner, managing member, officer, employee, agent or fiduciary of the Company or of any other corporation, limited liability company, partnership or joint venture, trust or other enterprise which such person is or was serving at the request of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">&#8220;Disinterested Director&#8221; shall mean a director of the Company who is not and was not a party to the Proceeding in respect of which indemnification is sought by Indemnitee.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">&#8220;Enterprise&#8221; shall mean the Company and any other corporation, limited liability company, partnership, joint venture, trust or other enterprise of which Indemnitee is or was serving at the request of the Company as a director, officer, trustee, partner, managing member, employee, agent or fiduciary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt">&#8220;Expenses&#8221; shall include all reasonable attorneys&#8217; fees, retainers, court costs, transcript costs, fees and other costs of experts and other professionals, witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees, any federal, state, local or foreign taxes imposed on Indemnitee as a result of the actual or deemed receipt of any payments under this Agreement, ERISA excise taxes and </font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:99.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">penalties, and all other disbursements, obligations or expenses of the types customarily incurred in connection with, or as a result of, prosecuting, defending, preparing to prosecute or defend, investigating, being or preparing to be a deponent or witness in, or otherwise participating in, a Proceeding.  Expenses also shall include (i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Expenses incurred in connection with any appeal resulting from any Proceeding, including without limitation the premium, security for, and other costs relating to any cost bond, supersedeas bond, or other appeal bond or its equivalent, (ii) Expenses incurred in connection with recovery under any directors&#8217; and officers&#8217; liability insurance policies maintained by the Company, regardless of whether Indemnitee is ultimately determined to be entitled to such indemnification, advancement or Expenses or insurance recovery, as the case may be, and (iii) for purposes of Section 14(d) only, Expenses incurred by Indemnitee in connection with the interpretation, enforcement or defense of Indemnitee's rights under this Agreement, the Charter, or under any directors&#8217; and officers&#8217; liability insurance policies maintained by the Company, by litigation or otherwise.  The parties agree that for the purposes of any advancement of Expenses for which Indemnitee has made written demand to the Company in accordance with this Agreement, all Expenses included in such demand that are certified by affidavit of Indemnitee's counsel as being reasonable in the good faith judgment of such counsel shall be presumed conclusively to be reasonable.  Expenses, however, shall not include amounts paid in settlement by Indemnitee or the amount of judgments or fines against Indemnitee.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">&#8220;Independent Counsel&#8221; shall mean a law firm, or a member of a law firm, that is experienced in matters of corporation law and neither presently is, nor in the past five years has been, retained to represent&#58;  (i) the Company or Indemnitee in any matter material to either such party (other than with respect to matters concerning the Indemnitee under this Agreement, or of other indemnitees under similar indemnification agreements), or (ii) any other party to the Proceeding giving rise to a claim for indemnification hereunder.  Notwithstanding the foregoing, the term &#8220;Independent Counsel&#8221; shall not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest in representing either the Company or Indemnitee in an action to determine Indemnitee&#8217;s rights under this Agreement.  The Company agrees to pay the reasonable fees and expenses of the Independent Counsel referred to above and to fully indemnify such counsel against any and all Expenses, claims, liabilities and damages arising out of or relating to this Agreement or its engagement pursuant hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The term &#8220;Proceeding&#8221; shall include any threatened, pending or completed action, suit, claim, counterclaim, cross claim, arbitration, mediation, alternate dispute resolution mechanism, investigation, inquiry, administrative hearing or any other actual, threatened or completed proceeding, whether brought in the right of the Company or otherwise and whether of a civil, criminal, administrative, legislative, regulatory or investigative (formal or informal) nature, including any appeal therefrom, in which Indemnitee was, is or will be involved as a party, potential party, non-party witness or otherwise by reason of Indemnitee&#8217;s Corporate Status, by reason of any action taken by Indemnitee (or a failure to take action by Indemnitee) or of any action (or failure to act) on Indemnitee&#8217;s part while acting pursuant to Indemnitee's Corporate Status, in each case whether or not serving in such capacity at the time any liability or Expense is incurred for which indemnification, reimbursement, or advancement of Expenses can be provided under this Agreement.  If the Indemnitee believes in good faith that a given situation may lead to or culminate in the institution of a Proceeding, this shall be considered a Proceeding under this paragraph.</font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:99.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">Reference to &#8220;other enterprise&#8221; shall include employee benefit plans&#59; references to &#8220;fines&#8221; shall include any excise tax assessed with respect to any employee benefit plan&#59; references to &#8220;serving at the request of the Company&#8221; shall include any service as a director, officer, employee or agent of the Company which imposes duties on, or involves services by, such director, officer, employee or agent with respect to an employee benefit plan, its participants or beneficiaries&#59; and a person who acted in good faith and in a manner Indemnitee  reasonably believed to be in the best interests of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner &#8220;not opposed to the best interests of the Company&#8221; as referred to in this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Indemnity in Third-Party Proceedings.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The Company shall indemnify Indemnitee in accordance with the provisions of this Section 3 if Indemnitee is, or is threatened to be made, a party to or a participant in any Proceeding, other than a Proceeding by or in the right of the Company to procure a judgment in its favor.  Pursuant to this Section 3, Indemnitee shall be indemnified to the fullest extent permitted by applicable law against all Expenses, judgments, fines and amounts paid in settlement (including all interest, assessments and other charges paid or payable in connection with or in respect of such Expenses, judgments, fines and amounts paid in settlement) actually and reasonably incurred by Indemnitee or on Indemnitee's behalf in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Company and, in the case of a criminal Proceeding had no reasonable cause to believe that Indemnitee's conduct was unlawful.  The parties hereto intend that this Agreement shall provide to the fullest extent permitted by law for indemnification in excess of that expressly permitted by statute, including, without limitation, any indemnification provided by the Charter, vote of the Company&#8217;s stockholders or disinterested directors or applicable law.</font></div><div style="margin-bottom:18pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Indemnity in Proceedings by or in the Right of the Company.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The Company shall indemnify Indemnitee in accordance with the provisions of this Section 4 if Indemnitee is, or is threatened to be made, a party to or a participant in any Proceeding by or in the right of the Company to procure a judgment in its favor.  Pursuant to this Section 4, Indemnitee shall be indemnified to the fullest extent permitted by applicable law against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee's behalf in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Company.  No indemnification for Expenses shall be made under this Section 4 in respect of any claim, issue or matter as to which Indemnitee shall have been finally adjudged by a court to be liable to the Company, unless and only to the extent that the Delaware Court (as hereinafter defined) or any court in which the Proceeding was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, Indemnitee is fairly and reasonably entitled to indemnification.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Indemnification for Expenses of a Party Who is Wholly or Partly Successful.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Notwithstanding any other provisions of this Agreement, to the fullest extent permitted by applicable law and to the extent that Indemnitee is a party to (or a participant in) and is successful, on the merits or otherwise, in any Proceeding or in defense of any claim, issue or matter therein, in whole or in part, the Company shall indemnify Indemnitee against all Expenses actually and reasonably incurred by or on behalf of Indemnitee in connection therewith.  If Indemnitee is not wholly successful in such Proceeding but is successful, on the merits or otherwise, as to one or more but less than all claims, issues or matters in such Proceeding, the Company shall indemnify Indemnitee against all Expenses actually and </font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:99.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">reasonably incurred by Indemnitee or on Indemnitee's behalf in connection with or related to each successfully resolved claim, issue or matter to the fullest extent permitted by law.  For purposes of this Section and without limitation, the termination of any claim, issue or matter in such a Proceeding by dismissal, with or without prejudice, shall be deemed to be a successful result as to such claim, issue or matter.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Indemnification For Expenses of a Witness.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  Notwithstanding any other provision of this Agreement, to the fullest extent permitted by applicable law and to the extent that Indemnitee is, by reason of Indemnitee&#8217;s Corporate Status, a witness, is or was made (or asked) to respond to discovery requests in any Proceeding, or otherwise asked to participate in any Proceeding to which Indemnitee is not a party, Indemnitee shall be indemnified against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee&#8217;s behalf in connection therewith.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Partial Indemnification.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  If Indemnitee is entitled under any provision of this Agreement to indemnification by the Company for some or a portion of Expenses, but not, however, for the total amount thereof, the Company shall nevertheless indemnify Indemnitee for the portion thereof to which Indemnitee is entitled.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Additional Indemnification.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Notwithstanding any limitation in Sections 3, 4, or 5, the Company shall indemnify Indemnitee to the fullest extent permitted by applicable law if Indemnitee is, or is threatened to be made, a party to or a participant in any Proceeding (including a Proceeding by or in the right of the Company to procure a judgment in its favor) by reason of Indemnitee&#8217;s Corporate Status. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">For purposes of Section 8(a), the meaning of the phrase &#8220;to the fullest extent permitted by applicable law&#8221; shall include, but not be limited to&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.67pt">to the fullest extent permitted by the provision of the DGCL that authorizes or contemplates additional indemnification by agreement, or the corresponding provision of any amendment to or replacement of the DGCL, and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.34pt">to the fullest extent authorized or permitted by any amendments to or replacements of the DGCL adopted after the date of this Agreement that increase the extent to which a corporation may indemnify its officers and directors.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Exclusions.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  Notwithstanding any provision in this Agreement, the Company shall not be obligated under this Agreement to make any indemnification payment in connection with any claim involving Indemnitee&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">for which payment has actually been made to or on behalf of Indemnitee under any insurance policy or other indemnity provision, except with respect to any excess beyond the amount paid under any insurance policy or other indemnity provision&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">for (i) an accounting of profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities of the Company within the meaning of Section 16(b) of the Exchange Act (as defined in Section 2(b) hereof) or similar provisions of state statutory law or common law, (ii) any reimbursement of the Company by the Indemnitee of any bonus or </font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:99.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">other incentive-based or equity-based compensation or of any profits realized by the Indemnitee from the sale of securities of the Company, as required in each case under the Exchange Act (including any such reimbursements that arise from an accounting restatement of the Company pursuant to Section 304 of the Sarbanes-Oxley Act of 2002 (the &#8220;Sarbanes-Oxley Act&#8221;), or the payment to the Company of profits arising from the purchase and sale by Indemnitee of securities in violation of Section 306 of the Sarbanes-Oxley Act) or (iii) any reimbursement of the Company by Indemnitee of any compensation pursuant to any compensation recoupment or clawback policy adopted by the Board or the compensation committee of the Board, including but not limited to any such policy adopted to comply with stock exchange listing requirements implementing Section 10D of the Exchange Act&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">except as provided in Section 14(d) of this Agreement, in connection with any Proceeding (or any part of any Proceeding) initiated by Indemnitee, including any Proceeding (or any part of any Proceeding) initiated by Indemnitee against the Company or its directors, officers, employees or other indemnitees, unless (i) the Board authorized the Proceeding (or any part of any Proceeding) prior to its initiation, (ii) such payment arises in connection with any mandatory counterclaim or cross claim brought or raised by Indemnitee in any Proceeding (or any part of any Proceeding), or (iii) the Company provides the indemnification, in its sole discretion, pursuant to the powers vested in the Company under applicable law.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Advances of Expenses.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  Notwithstanding any provision of this Agreement to the contrary (other than Section 14(d)), the Company shall advance, to the extent not prohibited by law, the Expenses incurred by or on behalf of Indemnitee in connection with any Proceeding (or any part of any Proceeding) not initiated by Indemnitee or any Proceeding initiated by Indemnitee with the prior approval of the Board as provided in Section 9(c), and such advancement shall be made within thirty (30) days after the receipt by the Company of a statement or statements requesting such advances from time to time, whether prior to or after final disposition of any Proceeding.  Advances shall be unsecured and interest free.  Advances shall be made without regard to Indemnitee's ability to repay the Expenses and without regard to Indemnitee's ultimate entitlement to indemnification under the other provisions of this Agreement.  In accordance with Section 14(d), advances shall include any and all reasonable Expenses incurred pursuing an action to enforce this right of advancement, including Expenses incurred preparing and forwarding statements to the Company to support the advances claimed.  The Indemnitee shall qualify for advances upon the execution and delivery to the Company of this Agreement, which shall constitute an undertaking providing that the Indemnitee undertakes to repay the amounts advanced (without interest) by the Company pursuant to this Section 10, if and only to the extent that it is ultimately determined that Indemnitee is not entitled to be indemnified by the Company.  No other form of undertaking shall be required other than the execution of this Agreement.  This Section 10 shall not apply to any claim made by Indemnitee for which indemnity is excluded pursuant to Section 9.</font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:99.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Procedure for Notification and Defense of Claim.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Indemnitee shall notify the Company in writing of any matter with respect to which Indemnitee intends to seek indemnification or advancement of Expenses hereunder as soon as reasonably practicable following the receipt by Indemnitee of written notice thereof.  The written notification to the Company shall include a description of the nature of the Proceeding and the facts underlying the Proceeding.  To obtain indemnification under this Agreement, Indemnitee shall submit to the Company a written request, including therein or therewith such documentation and information as is reasonably available to Indemnitee and is reasonably necessary to determine whether and to what extent Indemnitee is entitled to indemnification following the final disposition of such Proceeding.  The omission by Indemnitee to notify the Company hereunder will not relieve the Company from any liability which it may have to Indemnitee hereunder or otherwise than under this Agreement, and any delay in so notifying the Company shall not constitute a waiver by Indemnitee of any rights under this Agreement.  The Secretary of the Company shall, promptly upon receipt of such a request for indemnification, advise the Board in writing that Indemnitee has requested indemnification.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The Company will be entitled to participate in the Proceeding at its own expense.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Company shall not settle any Proceeding (in whole or in part) if such settlement would impose any Expense, judgment, liability, fine, penalty or limitation on Indemnitee in respect of which Indemnitee is not entitled to be indemnified hereunder without Indemnitee&#8217;s prior written consent, which shall not be unreasonably withheld. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Procedure Upon Application for Indemnification.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font></div><div style="margin-bottom:18pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Upon written request by Indemnitee for indemnification pursuant to Section 11(a), a determination, if required by applicable law, with respect to Indemnitee's entitlement thereto shall be made in the specific case&#58;  (i) if a Change in Control shall have occurred, by Independent Counsel in a written opinion to the Board, a copy of which shall be delivered to Indemnitee&#59; or (ii) if a Change in Control shall not have occurred, (A) by a majority vote of the Disinterested Directors, even though less than a quorum of the Board, (B) by a committee of Disinterested Directors designated by a majority vote of the Disinterested Directors, even though less than a quorum of the Board, (C) if there are no such Disinterested Directors or, if such Disinterested Directors so direct, by Independent Counsel in a written opinion to the Board, a copy of which shall be delivered to Indemnitee or (D) if so directed by the Board, by the stockholders of the Company&#59; and, if it is so determined that Indemnitee is entitled to indemnification, payment to Indemnitee shall be made within ten (10) days after such determination.  Indemnitee shall cooperate with the person, persons or entity making such determination with respect to Indemnitee's entitlement to indemnification, including providing to such person, persons or entity upon reasonable advance request any documentation or information which is not privileged or otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably necessary to such determination.  Any costs or Expenses (including attorneys' fees and disbursements) incurred by or on behalf of Indemnitee in so cooperating with the person, persons or entity making such determination shall be borne by the Company (irrespective of the determination as to Indemnitee's entitlement to indemnification) and the Company hereby indemnifies and agrees to hold Indemnitee harmless therefrom.  The Company promptly will advise Indemnitee in writing with respect to any </font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:99.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">determination that Indemnitee is or is not entitled to indemnification, including a description of any reason or basis for which indemnification has been denied.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">In the event the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to Section 12(a) hereof, the Independent Counsel shall be selected as provided in this Section&#160;12(b).  If a Change in Control shall not have occurred, the Independent Counsel shall be selected by the Board, and the Company shall give written notice to Indemnitee advising Indemnitee of the identity of the Independent Counsel so selected.  If a Change in Control shall have occurred, the Independent Counsel shall be selected by Indemnitee (unless Indemnitee shall request that such selection be made by the Board, in which event the preceding sentence shall apply), and Indemnitee shall give written notice to the Company advising it of the identity of the Independent Counsel so selected.  In either event, Indemnitee or the Company, as the case may be, may, within ten (10) days after such written notice of selection shall have been given, deliver to the Company or to Indemnitee, as the case may be, a written objection to such selection&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that such objection may be asserted only on the ground that the Independent Counsel so selected does not meet the requirements of &#34;Independent Counsel&#34; as defined in Section&#160;2 of this Agreement, and the objection shall set forth with particularity the factual basis of such assertion.  Absent a proper and timely objection, the person so selected shall act as Independent Counsel.  If such written objection is so made and substantiated, the Independent Counsel so selected may not serve as Independent Counsel unless and until such objection is withdrawn or the Delaware Court has determined that such objection is without merit.  If, within twenty (20) days after the later of submission by Indemnitee of a written request for indemnification pursuant to Section&#160;11(a) hereof and the final disposition of the Proceeding, no Independent Counsel shall have been selected and not objected to, either the Company or Indemnitee may petition the Delaware Court for resolution of any objection which shall have been made by the Company or Indemnitee to the other's selection of Independent Counsel and&#47;or for the appointment as Independent Counsel of a person selected by such court or by such other person as such court shall designate, and the person with respect to whom all objections are so resolved or the person so appointed shall act as Independent Counsel under Section&#160;12(a) hereof.  Upon the due commencement of any judicial proceeding or arbitration pursuant to Section 14(a) of this Agreement, Independent Counsel shall be discharged and relieved of any further responsibility in such capacity (subject to the applicable standards of professional conduct then prevailing).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">If the Company disputes a portion of the amounts for which indemnification is requested, the undisputed portion shall be paid and only the disputed portion withheld pending resolution of any such dispute. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Presumptions and Effect of Certain Proceedings.</font></div><div style="margin-bottom:18pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">In making a determination with respect to entitlement to indemnification hereunder, the person or persons or entity making such determination shall, to the fullest extent not prohibited by law, presume that Indemnitee is entitled to indemnification under this Agreement if Indemnitee has submitted a request for indemnification in accordance with Section 11(a) of this Agreement, and the Company shall, to the fullest extent not prohibited by law, have the burden of proof to overcome that presumption in connection with the making by any person, persons or entity of any determination contrary to that presumption.  Neither the failure of the Company (including by its directors or Independent Counsel) to have made a determination prior to the commencement of any action pursuant to this Agreement that indemnification is proper in the circumstances because Indemnitee has met the applicable standard of conduct, nor an actual </font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:99.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">determination by the Company (including by its directors or Independent Counsel) that Indemnitee has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that Indemnitee has not met the applicable standard of conduct.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Subject to Section 14(e), if the person, persons or entity empowered or selected under Section 12 of this Agreement to determine whether Indemnitee is entitled to indemnification shall not have made a determination within sixty (60) days after receipt by the Company of the request therefor, the requisite determination of entitlement to indemnification shall, to the fullest extent not prohibited by law, be deemed to have been made and Indemnitee shall be entitled to such indemnification, absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee&#8217;s statement not materially misleading, in connection with the request for indemnification, or (ii) a prohibition of such indemnification under applicable law&#59; provided, however, that such 60-day period may be extended for a reasonable time, not to exceed an additional thirty (30) days, if the person, persons or entity making the determination with respect to entitlement to indemnification in good faith requires such additional time for the obtaining or evaluating of documentation and&#47;or information relating thereto&#59; and provided, further, that the foregoing provisions of this Section 13(b) shall not apply (i) if the determination of entitlement to indemnification is to be made by the stockholders pursuant to Section 12(a) of this Agreement and if </font><font style="background-color:#e6e6e6;color:#2b579a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A) within fifteen (15) days after receipt by the Company of the request for such determination the Board has resolved to submit such determination to the stockholders for their consideration at an annual meeting thereof to be held within seventy-five (75) days after such receipt and such determination is made thereat, or (B) a special meeting of stockholders is called within fifteen (15) days after such receipt for the purpose of making such determination, such meeting is held for such purpose within sixty (60) days after having been so called and such determination is made thereat, or (ii) if the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to Section 12(a) of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon a plea of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">nolo</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">contendere</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> or its equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself adversely affect the right of Indemnitee to indemnification or create a presumption that Indemnitee did not act in good faith and in a manner which Indemnitee reasonably believed to be in or not opposed to the best interests of the Company or, with respect to any criminal Proceeding, that Indemnitee had reasonable cause to believe that Indemnitee's conduct was unlawful.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">For purposes of any determination of good faith, Indemnitee shall be deemed to have acted in good faith if Indemnitee&#8217;s action is based on the records or books of account of the Enterprise, including financial statements, or on information supplied to Indemnitee by the directors or officers of the Enterprise in the course of their duties, or on the advice of legal counsel for the Enterprise or on information or records given or reports made to the Enterprise by an independent certified public accountant or by an appraiser, financial advisor or other expert selected with reasonable care by or on behalf of the Enterprise.  The provisions of this Section 13(d) shall not be deemed to be exclusive or to limit in any way the other circumstances in which the Indemnitee may be deemed to have met the applicable standard of conduct set forth in this Agreement.</font></div><div style="margin-bottom:18pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The knowledge and&#47;or actions, or failure to act, of any director, officer, trustee, partner, managing member, fiduciary, agent or employee of the Enterprise shall not be </font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:99.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">imputed to Indemnitee for purposes of determining the right to indemnification under this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Remedies of Indemnitee.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Subject to Section 14(e), in the event that (i) a determination is made pursuant to Section 12 of this Agreement that Indemnitee is not entitled to indemnification under this Agreement, (ii) advancement of Expenses is not timely made pursuant to Section&#160;10 of this Agreement, (iii) no determination of entitlement to indemnification shall have been made pursuant to Section 12(a) of this Agreement within ninety (90) days after receipt by the Company of the request for indemnification, (iv) payment of indemnification is not made pursuant to Section&#160;5, 6 or 7 or the second to last sentence of Section 12(a) of this Agreement within ten (10) days after receipt by the Company of a written request therefor, (v) payment of indemnification pursuant to Section 3, 4 or 8 of this Agreement is not made within ten (10) days after a determination has been made that Indemnitee is entitled to indemnification, or (vi) the Company or any other person takes or threatens to take any action to declare this Agreement void or unenforceable, or institutes any litigation or other action or Proceeding designed to deny, or to recover from, the Indemnitee the benefits provided or intended to be provided to the Indemnitee hereunder, Indemnitee shall be entitled to an adjudication by a court of Indemnitee's entitlement to such indemnification or advancement of Expenses.  Alternatively, Indemnitee, at Indemnitee's option, may seek an award in arbitration to be conducted by a single arbitrator pursuant to the Commercial Arbitration Rules of the American Arbitration Association.  Indemnitee shall commence such proceeding seeking an adjudication or an award in arbitration within 180 days following the date on which Indemnitee first has the right to commence such proceeding pursuant to this Section 14(a).  The Company shall not oppose Indemnitee&#8217;s right to seek any such adjudication or award in arbitration. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">In the event that a determination shall have been made pursuant to Section 12(a) of this Agreement that Indemnitee is not entitled to indemnification, any judicial proceeding or arbitration commenced pursuant to this Section&#160;14 shall be conducted in all respects as a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">de</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">novo</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> trial, or arbitration, on the merits and Indemnitee shall not be prejudiced by reason of that adverse determination.  In any judicial proceeding or arbitration commenced pursuant to this Section 14, the Company shall have the burden of proving Indemnitee is not entitled to indemnification or advancement of Expenses, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">If a determination shall have been made pursuant to Section&#160;12(a) of this Agreement that Indemnitee is entitled to indemnification, the Company shall be bound by such determination in any judicial proceeding or arbitration commenced pursuant to this Section&#160;14, absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee&#8217;s statement not materially misleading, in connection with the request for indemnification, or (ii) a prohibition of such indemnification under applicable law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The Company shall, to the fullest extent not prohibited by law, be precluded from asserting in any judicial proceeding or arbitration commenced pursuant to this Section 14 that the procedures and presumptions of this Agreement are not valid, binding and enforceable and shall stipulate in any such court or before any such arbitrator that the Company is bound by all the provisions of this Agreement.  It is the intent of the Company that, to the fullest extent permitted by law, the Indemnitee not be required to incur legal fees or other Expenses associated with the interpretation, enforcement or defense of Indemnitee's rights under this Agreement by litigation or otherwise because the cost and expense thereof would </font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:99.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">substantially detract from the benefits intended to be extended to the Indemnitee hereunder.  The Company shall, to the fullest extent permitted by law, indemnify Indemnitee against any and all Expenses and, if requested by Indemnitee, shall (within ten (10) days after receipt by the Company of a written request therefor) advance, to the extent not prohibited by law, such Expenses to Indemnitee, which are incurred by or on behalf of Indemnitee in connection with any action brought by Indemnitee for indemnification or advancement of Expenses from the Company under this Agreement or under any directors' and officers' liability insurance policies maintained by the Company if, in the case of indemnification, Indemnitee is wholly successful on the underlying claims&#59; if Indemnitee is not wholly successful on the underlying claims, then such indemnification shall be only to the extent Indemnitee is successful on such underlying claims or otherwise as permitted by law, whichever is greater.</font></div><div style="margin-bottom:18pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Notwithstanding anything in this Agreement to the contrary, no determination as to entitlement of Indemnitee to indemnification under this Agreement shall be required to be made prior to the final disposition of the Proceeding.</font></div><div style="margin-bottom:18pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Non-exclusivity&#59; Survival of Rights&#59; Insurance&#59; Subrogation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The rights of indemnification and to receive advancement of Expenses as provided by this Agreement (i) shall not be deemed exclusive of any other rights to which Indemnitee may at any time be entitled under applicable law, the Charter, any agreement, a vote of stockholders or a resolution of directors, or otherwise and (ii) shall be interpreted independently of, and without reference to, any other such rights to which Indemnitee may at any time be entitled.  No amendment, alteration or repeal of this Agreement or of any provision hereof shall limit or restrict any right of Indemnitee under this Agreement in respect of any action taken or omitted by Indemnitee in Indemnitee's Corporate Status prior to such amendment, alteration or repeal.  To the extent that a change in Delaware law, whether by statute or judicial decision, permits greater indemnification or advancement of Expenses than would be afforded currently under the Charter and this Agreement, it is the intent of the parties hereto that Indemnitee shall enjoy by this Agreement the greater benefits so afforded by such change.  No right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every other right and remedy shall be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise.  The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other right or remedy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">To the extent that the Company maintains an insurance policy or policies providing liability insurance for directors, officers, employees, or agents of the Enterprise, Indemnitee shall be covered by such policy or policies in accordance with its or their terms to the maximum extent of the coverage available for any such director, officer, employee or agent under such policy or policies.  If, at the time of the receipt of a notice of a claim pursuant to the terms hereof, the Company has director and officer liability insurance in effect, the Company shall give prompt notice of such claim or of the commencement of a Proceeding, as the case may be, to the insurers in accordance with the procedures set forth in the respective policies.  The Company shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of the Indemnitee, all amounts payable as a result of such Proceeding in accordance with the terms of such policies.</font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:99.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">In the event of any payment made by the Company under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of recovery of Indemnitee, who shall execute all papers required and take all action necessary to secure such rights, including execution of such documents as are necessary to enable the Company to bring suit to enforce such rights.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The Company shall not be liable under this Agreement to make any payment of amounts otherwise indemnifiable hereunder (or for which advancement is provided hereunder) if and to the extent that Indemnitee has otherwise actually received such payment under any insurance policy, contract, agreement or otherwise.&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Company&#8217;s obligation to indemnify or advance Expenses hereunder to Indemnitee who is or was serving at the request of the Company as a director, officer, trustee, partner, managing member, fiduciary, employee or agent of any other corporation, limited liability company, partnership, joint venture, trust, employee benefit plan or other enterprise shall be reduced by any amount Indemnitee has actually received as indemnification or advancement of Expenses from such other corporation, limited liability company, partnership, joint venture, trust or other enterprise.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Duration of Agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  This Agreement shall continue until and terminate upon the later of&#58; (a) ten (10) years after the date that Indemnitee shall have ceased to serve as a director of the Company or (b) one (1) year after the final termination of any Proceeding then pending in respect of which Indemnitee is granted rights of indemnification or advancement of Expenses hereunder and of any proceeding (including any appeal thereof) commenced by Indemnitee pursuant to Section&#160;14 of this Agreement relating thereto.  The indemnification and advancement of expenses rights provided by or granted pursuant to this Agreement shall be binding upon and be enforceable by the parties hereto and their respective successors and assigns (including any direct or indirect successor by purchase, merger, consolidation or otherwise to all or substantially all of the business or assets of the Company), shall continue as to an Indemnitee who has ceased to be a director, officer, employee or agent of the Company or of any other Enterprise, and shall inure to the benefit of Indemnitee and Indemnitee&#8217;s spouse, assigns, heirs, devisees, executors and administrators and other legal representatives.  The Company shall require and shall cause any successor (whether direct or indirect by purchase, merger, consolidation or otherwise) to all or substantially all of the business or assets of the Company to, by written agreement, expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform if no such succession had taken place.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Severability.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Nothing in this Agreement is intended to require or shall be construed as requiring the Company to do or fail to do any act in violation of applicable law.  If any provision or provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever&#58; (a) the validity, legality and enforceability of the remaining provisions of this Agreement (including without limitation, each portion of any Section of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby and shall remain enforceable to the fullest extent permitted by law&#59; (b) such provision or provisions shall be deemed reformed to the extent necessary to conform to applicable law and to give the maximum effect to the intent of the parties hereto&#59; and (c) to the fullest extent possible, the provisions of this Agreement (including, without limitation, each portion of any Section of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not </font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:99.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">itself invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested thereby.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Enforcement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">This Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and supersedes all prior agreements and understandings, oral, written and implied, between the parties hereto with respect to the subject matter hereof&#59; provided, however, that this Agreement is a supplement to and in furtherance of the Charter, any directors&#8217; and officers&#8217; insurance maintained by the Company and applicable law, and shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 19.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Modification and Waiver.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by the parties hereto.  No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions of this Agreement nor shall any waiver constitute a continuing waiver.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 20.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Notice by Indemnitee.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  Indemnitee agrees promptly to notify the Company in writing upon being served with any summons, citation, subpoena, complaint, indictment, information or other document relating to any Proceeding or matter which may be subject to indemnification or advancement of Expenses covered hereunder.  The failure of Indemnitee to so notify the Company shall not relieve the Company of any obligation which it may have to the Indemnitee under this Agreement or otherwise. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 21.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Notices.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  All notices, requests, demands and other communications under this Agreement shall be in writing and shall be deemed to have been duly given if (a) delivered by hand and receipted for by the party to whom said notice or other communication shall have been directed, (b) mailed by certified or registered mail with postage prepaid, on the third business day after the date on which it is so mailed, (c) mailed by reputable overnight courier and receipted for by the party to whom said notice or other communication shall have been directed or (d) sent by email transmission, with receipt or other confirmation that such transmission has been received&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">If to Indemnitee, at the address indicated on the signature page of this Agreement, or such other address as Indemnitee shall provide to the Company.</font></div><div style="margin-bottom:18pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">If to the Company to</font></div><div style="margin-bottom:12pt;padding-left:72pt;padding-right:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Chief Legal Officer</font></div><div style="margin-bottom:12pt;padding-left:72pt;padding-right:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> agilon health, inc.</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> 440 Polaris Parkway, Suite 550</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Westerville, OH 43082</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or to any other address as may have been furnished to Indemnitee by the Company.</font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:99.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 22.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Contribution.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  To the fullest extent permissible under applicable law, if the indemnification provided for in this Agreement is unavailable to Indemnitee for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, shall contribute to the amount incurred by Indemnitee, whether for judgments, fines, penalties, excise taxes, amounts paid or to be paid in settlement and&#47;or for Expenses, in connection with any claim relating to an indemnifiable event under this Agreement, in such proportion as is deemed fair and reasonable in light of all of the circumstances of such Proceeding in order to reflect (i) the relative benefits received by the Company and Indemnitee as a result of the event(s) and&#47;or transaction(s) giving cause to such Proceeding&#59; and&#47;or (ii) the relative fault of the Company (and its directors, officers, employees and agents) and Indemnitee in connection with such event(s) and&#47;or transaction(s).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 23.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Applicable Law and Consent to Jurisdiction.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  This Agreement and the legal relations among the parties shall be governed by, and construed and enforced in accordance with, the laws of the State of Delaware, without regard to its conflict of laws rules.  Except with respect to any arbitration commenced by Indemnitee pursuant to Section 14(a) of this Agreement, the Company and Indemnitee hereby irrevocably and unconditionally (i) agree that any action or proceeding arising out of or in connection with this Agreement shall be brought only in the Court of Chancery of the State of Delaware (the &#8220;Delaware Court&#8221;), and not in any other state or federal court in the United States of America or any court in any other country, (ii) consent to submit to the exclusive jurisdiction of the Delaware Court for purposes of any action or proceeding arising out of or in connection with this Agreement, (iii) appoint, to the extent such party is not otherwise subject to service of process in the State of Delaware, irrevocably RL&#38;F Service Corp., 920 North King Street, 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">nd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Floor, Wilmington, New Castle County, Delaware 19801 as its agent in the State of Delaware as such party&#8217;s agent for acceptance of legal process in connection with any such action or proceeding against such party with the same legal force and validity as if served upon such party personally within the State of Delaware, (iv) waive any objection to the laying of venue of any such action or proceeding in the Delaware Court, and (v) waive, and agree not to plead or to make, any claim that any such action or proceeding brought in the Delaware Court has been brought in an improper or inconvenient forum.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 24.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Identical Counterparts.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original but all of which together shall constitute one and the same Agreement.  Only one such counterpart signed by the party against whom enforceability is sought needs to be produced to evidence the existence of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 25.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Miscellaneous.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The headings of this Agreement are inserted for convenience only and shall not be deemed to constitute part of this Agreement or to affect the construction thereof.</font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:99.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the parties have caused this Agreement to be effective as of the day and year first above written.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> agilon health, inc.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;INDEMNITEE<br><br><br>By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><br>Name&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Name&#58;<br>Title&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Address&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><br>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><br>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ex-102indemnificationagree.htm
<DESCRIPTION>EX-10.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i5bb2eff95cb2478b986f15149a242cb5_1"></div><div style="min-height:99.36pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Exhibit 10.2</font></div><div><font><br></font></div></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">INDEMNIFICATION AGREEMENT </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Indemnification Agreement (&#8220;Agreement&#8221;) is made as of ______, 2024 by and between agilon health, inc., a Delaware corporation (the &#8220;Company&#8221;), and &#91;Officer&#47;executive Name&#93; (&#34;Indemnitee&#34;).  This Agreement supersedes and replaces any and all previous Agreements between the Company and Indemnitee covering the subject matter of this Agreement.   </font></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">RECITALS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, each Amended and Restated Certificate of Incorporation of the Company (the &#8220;Certificate of Incorporation&#8221;) and the Amended and Restated Bylaws of the Company (the &#8220;Bylaws&#8221;, and together with the Certificate of Incorporation, the &#8220;Charter&#8221;) require indemnification of certain Officers and executives of the Company.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, Indemnitee may also be entitled to indemnification pursuant to the General Corporation Law of the State of Delaware (the &#8220;DGCL&#8221;).  The Charter and the DGCL expressly provide that the indemnification provisions set forth therein are not exclusive, and thereby contemplate that contracts may be entered into between the Company and members of the board of directors, officers and other persons with respect to indemnification&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, it is reasonable, prudent and necessary for the Company contractually to obligate itself to indemnify, and to advance expenses on behalf of, such persons to the fullest extent permitted by applicable law so that they may serve or continue to serve the Company free from undue concern that they will not be so indemnified&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, this Agreement is a supplement to and in furtherance of the Charter and any resolutions adopted pursuant thereto, as well as any rights of Indemnitees under any directors&#8217; and officers&#8217; liability insurance policy, and this Agreement shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">NOW, THEREFORE, in consideration of the premises and the covenants contained herein, the Company and Indemnitee do hereby covenant and agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Services to the Company.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  Indemnitee has agreed to serve as an officer or executive or other employee of the Company.  Indemnitee may at any time and for any reason resign from such position (subject to any other contractual obligation or any obligation imposed by operation of law), in which event the Company shall have no obligation under this Agreement to continue Indemnitee in such position.  This Agreement shall not be deemed an employment contract between the Company (or any of its subsidiaries or any Enterprise) and Indemnitee.  Indemnitee specifically acknowledges that Indemnitee's employment with the Company (or any of its subsidiaries or any Enterprise), if any, is at will, and the Indemnitee may be discharged at any time for any reason, with or without cause, except as may be otherwise provided in any written employment contract between Indemnitee and the Company (or any of its subsidiaries or </font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:99.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">any Enterprise), other applicable formal severance policies duly adopted by the Board, or, with respect to service as a director or officer of the Company, by the Charter and the DGCL.  The foregoing notwithstanding, this Agreement shall continue in force after Indemnitee has ceased to serve as an officer, director, executive, fiduciary or employee of the Company, as provided in Section 16 hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Definitions.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  As used in this Agreement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">References to &#8220;agent&#8221; shall mean any person who is or was a director, officer, or employee of the Company or a subsidiary of the Company or other person authorized by the Company to act for the Company, to include such person serving in such capacity as a director, officer, employee, executive, fiduciary or other official of another corporation, partnership, limited liability company, joint venture, trust or other enterprise at the request of, for the convenience of, or to represent the interests of the Company or a subsidiary of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">A &#8220;Change in Control&#8221; shall be deemed to occur upon the earliest to occur after the date of this Agreement of any of the following events&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.67pt">Acquisition of Stock by Third Party.  Any Person (as defined below) is or becomes the Beneficial Owner (as defined below), directly or indirectly, of securities of the Company representing fifty (50) percent  or more of the combined voting power of the Company's then outstanding securities unless the change in relative Beneficial Ownership of the Company's securities by any Person results solely from a reduction in the aggregate number of outstanding shares of securities entitled to vote generally in the election of directors&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.34pt">Change in Board of Directors.  During any period of two (2) consecutive years (not including any period prior to the execution of this Agreement), individuals who at the beginning of such period constitute the Board, and any new director (other than a director designated by a person who has entered into an agreement with the Company to effect a transaction described in Sections 2(b)(i), 2(b)(iii) or 2(b)(iv)) whose election by the Board or nomination for election by the Company's stockholders was approved by a vote of at least two-thirds of the directors then still in office who either were directors at the beginning of the period or whose election or nomination for election was previously so approved, cease for any reason to constitute at least a majority of the members of the Board&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.01pt">Corporate Transactions.  The effective date of a merger or consolidation of the Company with any other entity, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior to such merger or consolidation continuing to represent (either by remaining outstanding or by being converted into voting securities of the Surviving Entity) more than 50% of the combined voting power of the voting securities of the Surviving Entity outstanding immediately after such merger or consolidation and with the power to elect at least a majority of the board of directors or other governing body of such Surviving Entity&#59;</font></div><div style="margin-bottom:18pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.67pt">Liquidation.  The approval by the stockholders of the Company of a complete liquidation of the Company or an agreement for the sale or disposition by the Company of all or substantially all of the Company's assets&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Other Events.  There occurs any other event of a nature that would be required to be reported in response to Item 6(e) of Schedule 14A of Regulation 14A (or a </font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:99.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">response to any similar item on any similar schedule or form) promulgated under the Exchange Act (as defined below), whether or not the Company is then subject to such reporting requirement.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes of this Section 2(b), the following terms shall have the following meanings&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;padding-right:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;&#8220;Exchange Act&#8221; shall mean the Securities Exchange Act of 1934, as amended from time to time.</font></div><div style="margin-bottom:12pt;padding-left:72pt;padding-right:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;&#8220;Person&#8221; shall have the meaning as set forth in Sections 13(d) and 14(d) of the Exchange Act&#59; provided, however, that Person shall exclude (i) the Company, (ii) any trustee or other fiduciary holding securities under an employee benefit plan of the Company, and (iii) any entity owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of stock of the Company.  </font></div><div style="margin-bottom:12pt;padding-left:72pt;padding-right:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;&#8220;Beneficial Owner&#8221; shall have the meaning given to such term in Rule 13d-3 under the Exchange Act&#59; provided, however, that Beneficial Owner shall exclude any Person otherwise becoming a Beneficial Owner by reason of the stockholders of the Company approving a merger of the Company with another entity.</font></div><div style="margin-bottom:18pt;padding-left:72pt;padding-right:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;&#8220;Surviving Entity&#8221; shall mean the surviving entity in a merger or consolidation or any entity that controls, directly or indirectly, such surviving entity.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">&#8220;Corporate Status&#8221; describes the status of a person who is or was a director, trustee, partner, managing member, officer, employee, executive, agent or fiduciary of the Company or of any other corporation, limited liability company, partnership or joint venture, trust or other enterprise which such person is or was serving at the request of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">&#8220;Disinterested Director&#8221; shall mean a director of the Company who is not and was not a party to the Proceeding in respect of which indemnification is sought by Indemnitee.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">&#8220;Enterprise&#8221; shall mean the Company and any other corporation, limited liability company, partnership, joint venture, trust or other enterprise of which Indemnitee is or was serving at the request of the Company as a director, officer, executive, trustee, partner, managing member, employee, agent or fiduciary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt">&#8220;Expenses&#8221; shall include all reasonable attorneys&#8217; fees, retainers, court costs, transcript costs, fees and other costs of experts and other professionals, witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees, any federal, state, local or foreign taxes imposed on Indemnitee as a result of the </font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:99.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">actual or deemed receipt of any payments under this Agreement, ERISA excise taxes and penalties, and all other disbursements, obligations or expenses of the types customarily incurred in connection with, or as a result of, prosecuting, defending, preparing to prosecute or defend, investigating, being or preparing to be a deponent or witness in, or otherwise participating in, a Proceeding.  Expenses also shall include (i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Expenses incurred in connection with any appeal resulting from any Proceeding, including without limitation the premium, security for, and other costs relating to any cost bond, supersedeas bond, or other appeal bond or its equivalent, (ii) Expenses incurred in connection with recovery under any directors&#8217; and officers&#8217; liability insurance policies maintained by the Company, regardless of whether Indemnitee is ultimately determined to be entitled to such indemnification, advancement or Expenses or insurance recovery, as the case may be, and (iii) for purposes of Section 14(d) only, Expenses incurred by Indemnitee in connection with the interpretation, enforcement or defense of Indemnitee's rights under this Agreement, the Charter, or under any directors&#8217; and officers&#8217; liability insurance policies maintained by the Company, by litigation or otherwise.  The parties agree that for the purposes of any advancement of Expenses for which Indemnitee has made written demand to the Company in accordance with this Agreement, all Expenses included in such demand that are certified by affidavit of Indemnitee's counsel as being reasonable in the good faith judgment of such counsel shall be presumed conclusively to be reasonable.  Expenses, however, shall not include amounts paid in settlement by Indemnitee or the amount of judgments or fines against Indemnitee.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">&#8220;Independent Counsel&#8221; shall mean a law firm, or a member of a law firm, that is experienced in matters of corporation law and neither presently is, nor in the past five years has been, retained to represent&#58;  (i) the Company or Indemnitee in any matter material to either such party (other than with respect to matters concerning the Indemnitee under this Agreement, or of other indemnitees under similar indemnification agreements), or (ii) any other party to the Proceeding giving rise to a claim for indemnification hereunder.  Notwithstanding the foregoing, the term &#8220;Independent Counsel&#8221; shall not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest in representing either the Company or Indemnitee in an action to determine Indemnitee&#8217;s rights under this Agreement.  The Company agrees to pay the reasonable fees and expenses of the Independent Counsel referred to above and to fully indemnify such counsel against any and all Expenses, claims, liabilities and damages arising out of or relating to this Agreement or its engagement pursuant hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The term &#8220;Proceeding&#8221; shall include any threatened, pending or completed action, suit, claim, counterclaim, cross claim, arbitration, mediation, alternate dispute resolution mechanism, investigation, inquiry, administrative hearing or any other actual, threatened or completed proceeding, whether brought in the right of the Company or otherwise and whether of a civil, criminal, administrative, legislative, regulatory or investigative (formal or informal) nature, including any appeal therefrom, in which Indemnitee was, is or will be involved as a party, potential party, non-party witness or otherwise by reason of Indemnitee&#8217;s Corporate Status, by reason of any action taken by Indemnitee (or a failure to take action by Indemnitee) or of any action (or failure to act) on Indemnitee&#8217;s part while acting pursuant to Indemnitee's Corporate Status, in each case whether or not serving in such capacity at the time any liability or Expense is incurred for which indemnification, reimbursement, or advancement of Expenses can be provided under this Agreement.  If the Indemnitee believes in good faith that a given situation may lead to or culminate in the institution of a Proceeding, this shall be considered a Proceeding under this paragraph.</font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:99.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">Reference to &#8220;other enterprise&#8221; shall include employee benefit plans&#59; references to &#8220;fines&#8221; shall include any excise tax assessed with respect to any employee benefit plan&#59; references to &#8220;serving at the request of the Company&#8221; shall include any service as a director, officer, employee or agent of the Company which imposes duties on, or involves services by, such director, officer, employee or agent with respect to an employee benefit plan, its participants or beneficiaries&#59; and a person who acted in good faith and in a manner Indemnitee  reasonably believed to be in the best interests of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner &#8220;not opposed to the best interests of the Company&#8221; as referred to in this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Indemnity in Third-Party Proceedings.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The Company shall indemnify Indemnitee in accordance with the provisions of this Section 3 if Indemnitee is, or is threatened to be made, a party to or a participant in any Proceeding, other than a Proceeding by or in the right of the Company to procure a judgment in its favor.  Pursuant to this Section 3, Indemnitee shall be indemnified to the fullest extent permitted by applicable law against all Expenses, judgments, fines and amounts paid in settlement (including all interest, assessments and other charges paid or payable in connection with or in respect of such Expenses, judgments, fines and amounts paid in settlement) actually and reasonably incurred by Indemnitee or on Indemnitee's behalf in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Company and, in the case of a criminal Proceeding had no reasonable cause to believe that Indemnitee's conduct was unlawful.  The parties hereto intend that this Agreement shall provide to the fullest extent permitted by law for indemnification in excess of that expressly permitted by statute, including, without limitation, any indemnification provided by the Charter, vote of the Company&#8217;s stockholders or disinterested directors or applicable law.</font></div><div style="margin-bottom:18pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Indemnity in Proceedings by or in the Right of the Company.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The Company shall indemnify Indemnitee in accordance with the provisions of this Section 4 if Indemnitee is, or is threatened to be made, a party to or a participant in any Proceeding by or in the right of the Company to procure a judgment in its favor.  Pursuant to this Section 4, Indemnitee shall be indemnified to the fullest extent permitted by applicable law against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee's behalf in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Company.  No indemnification for Expenses shall be made under this Section 4 in respect of any claim, issue or matter as to which Indemnitee shall have been finally adjudged by a court to be liable to the Company, unless and only to the extent that the Delaware Court (as hereinafter defined) or any court in which the Proceeding was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, Indemnitee is fairly and reasonably entitled to indemnification.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Indemnification for Expenses of a Party Who is Wholly or Partly Successful.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Notwithstanding any other provisions of this Agreement, to the fullest extent permitted by applicable law and to the extent that Indemnitee is a party to (or a participant in) and is successful, on the merits or otherwise, in any Proceeding or in defense of any claim, issue or matter therein, in whole or in part, the Company shall indemnify Indemnitee against all Expenses actually and reasonably incurred by or on behalf of Indemnitee in connection therewith.  If Indemnitee is not wholly successful in such Proceeding but is successful, on the merits or otherwise, as to one or more but less than all claims, issues or matters in such Proceeding, the Company shall indemnify Indemnitee against all Expenses actually and </font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:99.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">reasonably incurred by Indemnitee or on Indemnitee's behalf in connection with or related to each successfully resolved claim, issue or matter to the fullest extent permitted by law.  For purposes of this Section and without limitation, the termination of any claim, issue or matter in such a Proceeding by dismissal, with or without prejudice, shall be deemed to be a successful result as to such claim, issue or matter.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Indemnification For Expenses of a Witness.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  Notwithstanding any other provision of this Agreement, to the fullest extent permitted by applicable law and to the extent that Indemnitee is, by reason of Indemnitee&#8217;s Corporate Status, a witness, is or was made (or asked) to respond to discovery requests in any Proceeding, or otherwise asked to participate in any Proceeding to which Indemnitee is not a party, Indemnitee shall be indemnified against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee&#8217;s behalf in connection therewith.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Partial Indemnification.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  If Indemnitee is entitled under any provision of this Agreement to indemnification by the Company for some or a portion of Expenses, but not, however, for the total amount thereof, the Company shall nevertheless indemnify Indemnitee for the portion thereof to which Indemnitee is entitled.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Additional Indemnification.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Notwithstanding any limitation in Sections 3, 4, or 5, the Company shall indemnify Indemnitee to the fullest extent permitted by applicable law if Indemnitee is, or is threatened to be made, a party to or a participant in any Proceeding (including a Proceeding by or in the right of the Company to procure a judgment in its favor) by reason of Indemnitee&#8217;s Corporate Status. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">For purposes of Section 8(a), the meaning of the phrase &#8220;to the fullest extent permitted by applicable law&#8221; shall include, but not be limited to&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.67pt">to the fullest extent permitted by the provision of the DGCL that authorizes or contemplates additional indemnification by agreement, or the corresponding provision of any amendment to or replacement of the DGCL, and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.34pt">to the fullest extent authorized or permitted by any amendments to or replacements of the DGCL adopted after the date of this Agreement that increase the extent to which a corporation may indemnify its officers, directors, executives and certain employees.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Exclusions.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  Notwithstanding any provision in this Agreement, the Company shall not be obligated under this Agreement to make any indemnification payment in connection with any claim involving Indemnitee&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">for which payment has actually been made to or on behalf of Indemnitee under any insurance policy or other indemnity provision, except with respect to any excess beyond the amount paid under any insurance policy or other indemnity provision&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">for (i) an accounting of profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities of the Company within the meaning of Section 16(b) of the Exchange Act (as defined in Section 2(b) hereof) or similar provisions of state statutory law or common law, (ii) any reimbursement of the Company by the Indemnitee of any bonus or </font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:99.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">other incentive-based or equity-based compensation or of any profits realized by the Indemnitee from the sale of securities of the Company, as required in each case under the Exchange Act (including any such reimbursements that arise from an accounting restatement of the Company pursuant to Section 304 of the Sarbanes-Oxley Act of 2002 (the &#8220;Sarbanes-Oxley Act&#8221;), or the payment to the Company of profits arising from the purchase and sale by Indemnitee of securities in violation of Section 306 of the Sarbanes-Oxley Act) or (iii) any reimbursement of the Company by Indemnitee of any compensation pursuant to any compensation recoupment or clawback policy adopted by the Board or the compensation committee of the Board, including but not limited to any such policy adopted to comply with stock exchange listing requirements implementing Section 10D of the Exchange Act&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">except as provided in Section 14(d) of this Agreement, in connection with any Proceeding (or any part of any Proceeding) initiated by Indemnitee, including any Proceeding (or any part of any Proceeding) initiated by Indemnitee against the Company or its directors, officers, employees or other indemnitees, unless (i) the Board authorized the Proceeding (or any part of any Proceeding) prior to its initiation, (ii) such payment arises in connection with any mandatory counterclaim or cross claim brought or raised by Indemnitee in any Proceeding (or any part of any Proceeding), or (iii) the Company provides the indemnification, in its sole discretion, pursuant to the powers vested in the Company under applicable law.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Advances of Expenses.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  Notwithstanding any provision of this Agreement to the contrary (other than Section 14(d)), the Company shall advance, to the extent not prohibited by law, the Expenses incurred by or on behalf of Indemnitee in connection with any Proceeding (or any part of any Proceeding) not initiated by Indemnitee or any Proceeding initiated by Indemnitee with the prior approval of the Board as provided in Section 9(c), and such advancement shall be made within thirty (30) days after the receipt by the Company of a statement or statements requesting such advances from time to time, whether prior to or after final disposition of any Proceeding.  Advances shall be unsecured and interest free.  Advances shall be made without regard to Indemnitee's ability to repay the Expenses and without regard to Indemnitee's ultimate entitlement to indemnification under the other provisions of this Agreement.  In accordance with Section 14(d), advances shall include any and all reasonable Expenses incurred pursuing an action to enforce this right of advancement, including Expenses incurred preparing and forwarding statements to the Company to support the advances claimed.  The Indemnitee shall qualify for advances upon the execution and delivery to the Company of this Agreement, which shall constitute an undertaking providing that the Indemnitee undertakes to repay the amounts advanced (without interest) by the Company pursuant to this Section 10, if and only to the extent that it is ultimately determined that Indemnitee is not entitled to be indemnified by the Company.  No other form of undertaking shall be required other than the execution of this Agreement.  This Section 10 shall not apply to any claim made by Indemnitee for which indemnity is excluded pursuant to Section 9.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Procedure for Notification and Defense of Claim.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Indemnitee shall notify the Company in writing of any matter with respect to which Indemnitee intends to seek indemnification or advancement of Expenses hereunder as soon as reasonably practicable following the receipt by Indemnitee of written notice thereof.  The written notification to the Company shall include a description of the nature of the Proceeding and the facts underlying the Proceeding.  To obtain indemnification under this Agreement, Indemnitee shall submit to the Company a written request, including therein or therewith such </font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:99.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">documentation and information as is reasonably available to Indemnitee and is reasonably necessary to determine whether and to what extent Indemnitee is entitled to indemnification following the final disposition of such Proceeding.  The omission by Indemnitee to notify the Company hereunder will not relieve the Company from any liability which it may have to Indemnitee hereunder or otherwise than under this Agreement, and any delay in so notifying the Company shall not constitute a waiver by Indemnitee of any rights under this Agreement.  The Secretary of the Company shall, promptly upon receipt of such a request for indemnification, advise the Board in writing that Indemnitee has requested indemnification.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The Company will be entitled to participate in the Proceeding at its own expense.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Company shall not settle any Proceeding (in whole or in part) if such settlement would impose any Expense, judgment, liability, fine, penalty or limitation on Indemnitee in respect of which Indemnitee is not entitled to be indemnified hereunder without Indemnitee&#8217;s prior written consent, which shall not be unreasonably withheld. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Procedure Upon Application for Indemnification.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font></div><div style="margin-bottom:18pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Upon written request by Indemnitee for indemnification pursuant to Section 11(a), a determination, if required by applicable law, with respect to Indemnitee's entitlement thereto shall be made in the specific case&#58;  (i) if a Change in Control shall have occurred, by Independent Counsel in a written opinion to the Board, a copy of which shall be delivered to Indemnitee&#59; or (ii) if a Change in Control shall not have occurred, (A) by a majority vote of the Disinterested Directors, even though less than a quorum of the Board, (B) by a committee of Disinterested Directors designated by a majority vote of the Disinterested Directors, even though less than a quorum of the Board, (C) if there are no such Disinterested Directors or, if such Disinterested Directors so direct, by Independent Counsel in a written opinion to the Board, a copy of which shall be delivered to Indemnitee or (D) if so directed by the Board, by the stockholders of the Company&#59; and, if it is so determined that Indemnitee is entitled to indemnification, payment to Indemnitee shall be made within ten (10) days after such determination.  Indemnitee shall cooperate with the person, persons or entity making such determination with respect to Indemnitee's entitlement to indemnification, including providing to such person, persons or entity upon reasonable advance request any documentation or information which is not privileged or otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably necessary to such determination.  Any costs or Expenses (including attorneys' fees and disbursements) incurred by or on behalf of Indemnitee in so cooperating with the person, persons or entity making such determination shall be borne by the Company (irrespective of the determination as to Indemnitee's entitlement to indemnification) and the Company hereby indemnifies and agrees to hold Indemnitee harmless therefrom.  The Company promptly will advise Indemnitee in writing with respect to any determination that Indemnitee is or is not entitled to indemnification, including a description of any reason or basis for which indemnification has been denied.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">In the event the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to Section 12(a) hereof, the Independent Counsel shall be selected as provided in this Section&#160;12(b).  If a Change in Control shall not have occurred, the Independent Counsel shall be selected by the Board, and the Company shall give written notice to Indemnitee advising Indemnitee of the identity of the Independent Counsel so selected.  If a Change in Control shall have occurred, the Independent Counsel shall be selected by Indemnitee </font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:99.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(unless Indemnitee shall request that such selection be made by the Board, in which event the preceding sentence shall apply), and Indemnitee shall give written notice to the Company advising it of the identity of the Independent Counsel so selected.  In either event, Indemnitee or the Company, as the case may be, may, within ten (10) days after such written notice of selection shall have been given, deliver to the Company or to Indemnitee, as the case may be, a written objection to such selection&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that such objection may be asserted only on the ground that the Independent Counsel so selected does not meet the requirements of &#34;Independent Counsel&#34; as defined in Section&#160;2 of this Agreement, and the objection shall set forth with particularity the factual basis of such assertion.  Absent a proper and timely objection, the person so selected shall act as Independent Counsel.  If such written objection is so made and substantiated, the Independent Counsel so selected may not serve as Independent Counsel unless and until such objection is withdrawn or the Delaware Court has determined that such objection is without merit.  If, within twenty (20) days after the later of submission by Indemnitee of a written request for indemnification pursuant to Section&#160;11(a) hereof and the final disposition of the Proceeding, no Independent Counsel shall have been selected and not objected to, either the Company or Indemnitee may petition the Delaware Court for resolution of any objection which shall have been made by the Company or Indemnitee to the other's selection of Independent Counsel and&#47;or for the appointment as Independent Counsel of a person selected by such court or by such other person as such court shall designate, and the person with respect to whom all objections are so resolved or the person so appointed shall act as Independent Counsel under Section&#160;12(a) hereof.  Upon the due commencement of any judicial proceeding or arbitration pursuant to Section 14(a) of this Agreement, Independent Counsel shall be discharged and relieved of any further responsibility in such capacity (subject to the applicable standards of professional conduct then prevailing).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">If the Company disputes a portion of the amounts for which indemnification is requested, the undisputed portion shall be paid and only the disputed portion withheld pending resolution of any such dispute. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Presumptions and Effect of Certain Proceedings.</font></div><div style="margin-bottom:18pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">In making a determination with respect to entitlement to indemnification hereunder, the person or persons or entity making such determination shall, to the fullest extent not prohibited by law, presume that Indemnitee is entitled to indemnification under this Agreement if Indemnitee has submitted a request for indemnification in accordance with Section 11(a) of this Agreement, and the Company shall, to the fullest extent not prohibited by law, have the burden of proof to overcome that presumption in connection with the making by any person, persons or entity of any determination contrary to that presumption.  Neither the failure of the Company (including by its directors or Independent Counsel) to have made a determination prior to the commencement of any action pursuant to this Agreement that indemnification is proper in the circumstances because Indemnitee has met the applicable standard of conduct, nor an actual determination by the Company (including by its directors or Independent Counsel) that Indemnitee has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that Indemnitee has not met the applicable standard of conduct.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Subject to Section 14(e), if the person, persons or entity empowered or selected under Section 12 of this Agreement to determine whether Indemnitee is entitled to indemnification shall not have made a determination within sixty (60) days after receipt by the Company of the request therefor, the requisite determination of entitlement to indemnification shall, to the fullest extent not prohibited by law, be deemed to have been made and Indemnitee </font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:99.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">shall be entitled to such indemnification, absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee&#8217;s statement not materially misleading, in connection with the request for indemnification, or (ii) a prohibition of such indemnification under applicable law&#59; provided, however, that such 60-day period may be extended for a reasonable time, not to exceed an additional thirty (30) days, if the person, persons or entity making the determination with respect to entitlement to indemnification in good faith requires such additional time for the obtaining or evaluating of documentation and&#47;or information relating thereto&#59; and provided, further, that the foregoing provisions of this Section 13(b) shall not apply (i) if the determination of entitlement to indemnification is to be made by the stockholders pursuant to Section 12(a) of this Agreement and if </font><font style="background-color:#e6e6e6;color:#2b579a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A) within fifteen (15) days after receipt by the Company of the request for such determination the Board has resolved to submit such determination to the stockholders for their consideration at an annual meeting thereof to be held within seventy-five (75) days after such receipt and such determination is made thereat, or (B) a special meeting of stockholders is called within fifteen (15) days after such receipt for the purpose of making such determination, such meeting is held for such purpose within sixty (60) days after having been so called and such determination is made thereat, or (ii) if the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to Section 12(a) of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon a plea of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">nolo</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">contendere</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> or its equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself adversely affect the right of Indemnitee to indemnification or create a presumption that Indemnitee did not act in good faith and in a manner which Indemnitee reasonably believed to be in or not opposed to the best interests of the Company or, with respect to any criminal Proceeding, that Indemnitee had reasonable cause to believe that Indemnitee's conduct was unlawful.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">For purposes of any determination of good faith, Indemnitee shall be deemed to have acted in good faith if Indemnitee&#8217;s action is based on the records or books of account of the Enterprise, including financial statements, or on information supplied to Indemnitee by the directors or officers of the Enterprise in the course of their duties, or on the advice of legal counsel for the Enterprise or on information or records given or reports made to the Enterprise by an independent certified public accountant or by an appraiser, financial advisor or other expert selected with reasonable care by or on behalf of the Enterprise.  The provisions of this Section 13(d) shall not be deemed to be exclusive or to limit in any way the other circumstances in which the Indemnitee may be deemed to have met the applicable standard of conduct set forth in this Agreement.</font></div><div style="margin-bottom:18pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The knowledge and&#47;or actions, or failure to act, of any director, officer, trustee, partner, managing member, fiduciary, agent or employee of the Enterprise shall not be imputed to Indemnitee for purposes of determining the right to indemnification under this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Remedies of Indemnitee.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Subject to Section 14(e), in the event that (i) a determination is made pursuant to Section 12 of this Agreement that Indemnitee is not entitled to indemnification under this Agreement, (ii) advancement of Expenses is not timely made pursuant to Section&#160;10 of this Agreement, (iii) no determination of entitlement to indemnification shall have been made pursuant to Section 12(a) of this Agreement within ninety (90) days after receipt by the Company </font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:99.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">of the request for indemnification, (iv) payment of indemnification is not made pursuant to Section&#160;5, 6 or 7 or the second to last sentence of Section 12(a) of this Agreement within ten (10) days after receipt by the Company of a written request therefor, (v) payment of indemnification pursuant to Section 3, 4 or 8 of this Agreement is not made within ten (10) days after a determination has been made that Indemnitee is entitled to indemnification, or (vi) the Company or any other person takes or threatens to take any action to declare this Agreement void or unenforceable, or institutes any litigation or other action or Proceeding designed to deny, or to recover from, the Indemnitee the benefits provided or intended to be provided to the Indemnitee hereunder, Indemnitee shall be entitled to an adjudication by a court of Indemnitee's entitlement to such indemnification or advancement of Expenses.  Alternatively, Indemnitee, at Indemnitee's option, may seek an award in arbitration to be conducted by a single arbitrator pursuant to the Commercial Arbitration Rules of the American Arbitration Association.  Indemnitee shall commence such proceeding seeking an adjudication or an award in arbitration within 180 days following the date on which Indemnitee first has the right to commence such proceeding pursuant to this Section 14(a).  The Company shall not oppose Indemnitee&#8217;s right to seek any such adjudication or award in arbitration. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">In the event that a determination shall have been made pursuant to Section 12(a) of this Agreement that Indemnitee is not entitled to indemnification, any judicial proceeding or arbitration commenced pursuant to this Section&#160;14 shall be conducted in all respects as a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">de</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">novo</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> trial, or arbitration, on the merits and Indemnitee shall not be prejudiced by reason of that adverse determination.  In any judicial proceeding or arbitration commenced pursuant to this Section 14, the Company shall have the burden of proving Indemnitee is not entitled to indemnification or advancement of Expenses, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">If a determination shall have been made pursuant to Section&#160;12(a) of this Agreement that Indemnitee is entitled to indemnification, the Company shall be bound by such determination in any judicial proceeding or arbitration commenced pursuant to this Section&#160;14, absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee&#8217;s statement not materially misleading, in connection with the request for indemnification, or (ii) a prohibition of such indemnification under applicable law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The Company shall, to the fullest extent not prohibited by law, be precluded from asserting in any judicial proceeding or arbitration commenced pursuant to this Section 14 that the procedures and presumptions of this Agreement are not valid, binding and enforceable and shall stipulate in any such court or before any such arbitrator that the Company is bound by all the provisions of this Agreement.  It is the intent of the Company that, to the fullest extent permitted by law, the Indemnitee not be required to incur legal fees or other Expenses associated with the interpretation, enforcement or defense of Indemnitee's rights under this Agreement by litigation or otherwise because the cost and expense thereof would substantially detract from the benefits intended to be extended to the Indemnitee hereunder.  The Company shall, to the fullest extent permitted by law, indemnify Indemnitee against any and all Expenses and, if requested by Indemnitee, shall (within ten (10) days after receipt by the Company of a written request therefor) advance, to the extent not prohibited by law, such Expenses to Indemnitee, which are incurred by or on behalf of Indemnitee in connection with any action brought by Indemnitee for indemnification or advancement of Expenses from the Company under this Agreement or under any directors' and officers' liability insurance policies maintained by the Company if, in the case of indemnification, Indemnitee is wholly successful on the underlying claims&#59; if Indemnitee is not wholly successful on the underlying claims, then </font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:99.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">such indemnification shall be only to the extent Indemnitee is successful on such underlying claims or otherwise as permitted by law, whichever is greater.</font></div><div style="margin-bottom:18pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Notwithstanding anything in this Agreement to the contrary, no determination as to entitlement of Indemnitee to indemnification under this Agreement shall be required to be made prior to the final disposition of the Proceeding.</font></div><div style="margin-bottom:18pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Non-exclusivity&#59; Survival of Rights&#59; Insurance&#59; Subrogation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The rights of indemnification and to receive advancement of Expenses as provided by this Agreement (i) shall not be deemed exclusive of any other rights to which Indemnitee may at any time be entitled under applicable law, the Charter, any agreement, a vote of stockholders or a resolution of directors, or otherwise and (ii) shall be interpreted independently of, and without reference to, any other such rights to which Indemnitee may at any time be entitled.  No amendment, alteration or repeal of this Agreement or of any provision hereof shall limit or restrict any right of Indemnitee under this Agreement in respect of any action taken or omitted by Indemnitee in Indemnitee's Corporate Status prior to such amendment, alteration or repeal.  To the extent that a change in Delaware law, whether by statute or judicial decision, permits greater indemnification or advancement of Expenses than would be afforded currently under the Charter and this Agreement, it is the intent of the parties hereto that Indemnitee shall enjoy by this Agreement the greater benefits so afforded by such change.  No right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every other right and remedy shall be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise.  The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other right or remedy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">To the extent that the Company maintains an insurance policy or policies providing liability insurance for directors, officers, employees, or agents of the Enterprise, Indemnitee shall be covered by such policy or policies in accordance with its or their terms to the maximum extent of the coverage available for any such director, officer, employee or agent under such policy or policies.  If, at the time of the receipt of a notice of a claim pursuant to the terms hereof, the Company has director and officer liability insurance in effect, the Company shall give prompt notice of such claim or of the commencement of a Proceeding, as the case may be, to the insurers in accordance with the procedures set forth in the respective policies.  The Company shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of the Indemnitee, all amounts payable as a result of such Proceeding in accordance with the terms of such policies.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">In the event of any payment made by the Company under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of recovery of Indemnitee, who shall execute all papers required and take all action necessary to secure such rights, including execution of such documents as are necessary to enable the Company to bring suit to enforce such rights.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The Company shall not be liable under this Agreement to make any payment of amounts otherwise indemnifiable hereunder (or for which advancement is provided hereunder) if and to the extent that Indemnitee has otherwise actually received such payment under any insurance policy, contract, agreement or otherwise.&#160;&#160;&#160;&#160;</font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:99.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Company&#8217;s obligation to indemnify or advance Expenses hereunder to Indemnitee who is or was serving at the request of the Company as a director, officer, trustee, partner, managing member, fiduciary, employee or agent of any other corporation, limited liability company, partnership, joint venture, trust, employee benefit plan or other enterprise shall be reduced by any amount Indemnitee has actually received as indemnification or advancement of Expenses from such other corporation, limited liability company, partnership, joint venture, trust or other enterprise.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Duration of Agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  This Agreement shall continue until and terminate upon the later of&#58; (a) ten (10) years after the date that Indemnitee shall have ceased to serve as an officer, executive or employee of the Company or (b) one (1) year after the final termination of any Proceeding then pending in respect of which Indemnitee is granted rights of indemnification or advancement of Expenses hereunder and of any proceeding (including any appeal thereof) commenced by Indemnitee pursuant to Section&#160;14 of this Agreement relating thereto.  The indemnification and advancement of expenses rights provided by or granted pursuant to this Agreement shall be binding upon and be enforceable by the parties hereto and their respective successors and assigns (including any direct or indirect successor by purchase, merger, consolidation or otherwise to all or substantially all of the business or assets of the Company), shall continue as to an Indemnitee who has ceased to be a director, officer, employee or agent of the Company or of any other Enterprise, and shall inure to the benefit of Indemnitee and Indemnitee&#8217;s spouse, assigns, heirs, devisees, executors and administrators and other legal representatives.  The Company shall require and shall cause any successor (whether direct or indirect by purchase, merger, consolidation or otherwise) to all or substantially all of the business or assets of the Company to, by written agreement, expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform if no such succession had taken place.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Severability.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Nothing in this Agreement is intended to require or shall be construed as requiring the Company to do or fail to do any act in violation of applicable law.  If any provision or provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever&#58; (a) the validity, legality and enforceability of the remaining provisions of this Agreement (including without limitation, each portion of any Section of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby and shall remain enforceable to the fullest extent permitted by law&#59; (b) such provision or provisions shall be deemed reformed to the extent necessary to conform to applicable law and to give the maximum effect to the intent of the parties hereto&#59; and (c) to the fullest extent possible, the provisions of this Agreement (including, without limitation, each portion of any Section of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested thereby.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Enforcement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">This Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and supersedes all prior agreements and understandings, oral, written and implied, between the parties hereto with respect to the subject matter hereof&#59; provided, however, that this Agreement is a supplement to and in furtherance of the Charter, any directors&#8217; and officers&#8217; insurance maintained by the Company and applicable </font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:99.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">law, and shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 19.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Modification and Waiver.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by the parties hereto.  No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions of this Agreement nor shall any waiver constitute a continuing waiver.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 20.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Notice by Indemnitee.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  Indemnitee agrees promptly to notify the Company in writing upon being served with any summons, citation, subpoena, complaint, indictment, information or other document relating to any Proceeding or matter which may be subject to indemnification or advancement of Expenses covered hereunder.  The failure of Indemnitee to so notify the Company shall not relieve the Company of any obligation which it may have to the Indemnitee under this Agreement or otherwise. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 21.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Notices.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  All notices, requests, demands and other communications under this Agreement shall be in writing and shall be deemed to have been duly given if (a) delivered by hand and receipted for by the party to whom said notice or other communication shall have been directed, (b) mailed by certified or registered mail with postage prepaid, on the third business day after the date on which it is so mailed, (c) mailed by reputable overnight courier and receipted for by the party to whom said notice or other communication shall have been directed or (d) sent by email transmission, with receipt or other confirmation that such transmission has been received&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">If to Indemnitee, at the address indicated on the signature page of this Agreement, or such other address as Indemnitee shall provide to the Company.</font></div><div style="margin-bottom:18pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">If to the Company to</font></div><div style="margin-bottom:12pt;padding-left:72pt;padding-right:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Chief Legal Officer</font></div><div style="margin-bottom:12pt;padding-left:72pt;padding-right:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> agilon health, inc.</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> 440 Polaris Parkway, Suite 550, </font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Westerville, OH 43082</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or to any other address as may have been furnished to Indemnitee by the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 22.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Contribution.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  To the fullest extent permissible under applicable law, if the indemnification provided for in this Agreement is unavailable to Indemnitee for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, shall contribute to the amount incurred by Indemnitee, whether for judgments, fines, penalties, excise taxes, amounts paid or to be paid in settlement and&#47;or for Expenses, in connection with any claim relating to an indemnifiable event under this Agreement, in such proportion as is deemed fair and reasonable in light of all of the circumstances of such Proceeding in order to reflect (i) the relative benefits received by the Company and Indemnitee as a result of the event(s) and&#47;or transaction(s) giving cause to such Proceeding&#59; and&#47;or (ii) the relative fault of the Company (and its directors, officers, employees and agents) and Indemnitee in connection with such event(s) and&#47;or transaction(s).</font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:99.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 23.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Applicable Law and Consent to Jurisdiction.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  This Agreement and the legal relations among the parties shall be governed by, and construed and enforced in accordance with, the laws of the State of Delaware, without regard to its conflict of laws rules.  Except with respect to any arbitration commenced by Indemnitee pursuant to Section 14(a) of this Agreement, the Company and Indemnitee hereby irrevocably and unconditionally (i) agree that any action or proceeding arising out of or in connection with this Agreement shall be brought only in the Court of Chancery of the State of Delaware (the &#8220;Delaware Court&#8221;), and not in any other state or federal court in the United States of America or any court in any other country, (ii) consent to submit to the exclusive jurisdiction of the Delaware Court for purposes of any action or proceeding arising out of or in connection with this Agreement, (iii) appoint, to the extent such party is not otherwise subject to service of process in the State of Delaware, irrevocably RL&#38;F Service Corp., 920 North King Street, 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">nd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Floor, Wilmington, New Castle County, Delaware 19801 as its agent in the State of Delaware as such party&#8217;s agent for acceptance of legal process in connection with any such action or proceeding against such party with the same legal force and validity as if served upon such party personally within the State of Delaware, (iv) waive any objection to the laying of venue of any such action or proceeding in the Delaware Court, and (v) waive, and agree not to plead or to make, any claim that any such action or proceeding brought in the Delaware Court has been brought in an improper or inconvenient forum.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 24.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Identical Counterparts.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original but all of which together shall constitute one and the same Agreement.  Only one such counterpart signed by the party against whom enforceability is sought needs to be produced to evidence the existence of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 25.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Miscellaneous.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The headings of this Agreement are inserted for convenience only and shall not be deemed to constitute part of this Agreement or to affect the construction thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the parties have caused this Agreement to be effective as of the day and year first above written.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> agilon health, inc.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;INDEMNITEE<br><br><br>By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><br>Name&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Name&#58;<br>Title&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Address&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><br>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><br>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>agl-20241204.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:17fb4859-5918-4cfb-84e0-0b572b54c452,g:8a35e750-400b-4819-bea7-8c5b4698656a-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:agl="http://agilonhealth.com/20241204" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://agilonhealth.com/20241204">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="agl-20241204_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="agl-20241204_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="agl-20241204_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://agilonhealth.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>agl-20241204_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:17fb4859-5918-4cfb-84e0-0b572b54c452,g:8a35e750-400b-4819-bea7-8c5b4698656a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://agilonhealth.com/role/Cover" xlink:type="simple" xlink:href="agl-20241204.xsd#Cover"/>
  <link:definitionLink xlink:role="http://agilonhealth.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_830efde0-3e01-4728-b71c-0682e5ce7aeb" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_DocumentInformationTable_830efde0-3e01-4728-b71c-0682e5ce7aeb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_120e6e95-e588-49e6-84f9-7d6c66e8be7a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_830efde0-3e01-4728-b71c-0682e5ce7aeb" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_120e6e95-e588-49e6-84f9-7d6c66e8be7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_120e6e95-e588-49e6-84f9-7d6c66e8be7a_default" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_120e6e95-e588-49e6-84f9-7d6c66e8be7a" xlink:to="loc_dei_AddressTypeDomain_120e6e95-e588-49e6-84f9-7d6c66e8be7a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_e681181b-9b38-477e-837d-499d8140a453" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_120e6e95-e588-49e6-84f9-7d6c66e8be7a" xlink:to="loc_dei_AddressTypeDomain_e681181b-9b38-477e-837d-499d8140a453" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_FormerAddressMember_2f1e6590-d85c-4a51-863b-690108bf1c0a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_FormerAddressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_AddressTypeDomain_e681181b-9b38-477e-837d-499d8140a453" xlink:to="loc_dei_FormerAddressMember_2f1e6590-d85c-4a51-863b-690108bf1c0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_dedb13dd-590f-4f23-aad8-5fe4272e8a5c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_DocumentType_dedb13dd-590f-4f23-aad8-5fe4272e8a5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_74860fe5-185f-451b-8fc7-165392898a79" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_DocumentPeriodEndDate_74860fe5-185f-451b-8fc7-165392898a79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_59aa65f5-0f2a-4d14-a0e9-91f65b791254" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_EntityRegistrantName_59aa65f5-0f2a-4d14-a0e9-91f65b791254" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_60c799b5-c513-4481-a5fc-e932921c5bd8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_EntityIncorporationStateCountryCode_60c799b5-c513-4481-a5fc-e932921c5bd8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_693cfacb-09a6-4e0d-bdad-f1c06efe89fc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_EntityFileNumber_693cfacb-09a6-4e0d-bdad-f1c06efe89fc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_e1e0ce93-de1f-405c-bcc4-1a38ea2090f4" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_EntityTaxIdentificationNumber_e1e0ce93-de1f-405c-bcc4-1a38ea2090f4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_496aff1b-0e41-4618-b7fc-6350e18a8908" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_EntityAddressAddressLine1_496aff1b-0e41-4618-b7fc-6350e18a8908" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_93b4d9a9-8435-4e7d-a44c-e4e5131b0a71" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_EntityAddressAddressLine2_93b4d9a9-8435-4e7d-a44c-e4e5131b0a71" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_6e7bedc1-938d-4955-91ec-f8cef4dfebf5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_EntityAddressCityOrTown_6e7bedc1-938d-4955-91ec-f8cef4dfebf5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_9443fe68-7f1c-4fef-b899-40236ebb6aee" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_EntityAddressStateOrProvince_9443fe68-7f1c-4fef-b899-40236ebb6aee" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_9af06eeb-83ad-4a47-bbb8-984290c3bdc5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_EntityAddressPostalZipCode_9af06eeb-83ad-4a47-bbb8-984290c3bdc5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_4fff7fb6-3caa-48d4-8d9f-ecb6fd840f70" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_CityAreaCode_4fff7fb6-3caa-48d4-8d9f-ecb6fd840f70" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_82ad377e-d231-43c8-8090-d605f49a63c1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_LocalPhoneNumber_82ad377e-d231-43c8-8090-d605f49a63c1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_68ca1b14-f487-4939-a0c9-10625e260914" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_WrittenCommunications_68ca1b14-f487-4939-a0c9-10625e260914" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_ca9b86bb-7d9d-4bb5-9d0e-d3ee4f77266f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_SolicitingMaterial_ca9b86bb-7d9d-4bb5-9d0e-d3ee4f77266f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_098963de-63a1-4c7f-9e81-ccdd8d7ec79c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_PreCommencementTenderOffer_098963de-63a1-4c7f-9e81-ccdd8d7ec79c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_4e252e2d-6210-4849-9489-21b660216b07" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_4e252e2d-6210-4849-9489-21b660216b07" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_565a3033-6f1d-4006-b7c9-b3ee1b2624da" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_Security12bTitle_565a3033-6f1d-4006-b7c9-b3ee1b2624da" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_262e6818-9397-4ed9-a1e3-6901f0288a03" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_TradingSymbol_262e6818-9397-4ed9-a1e3-6901f0288a03" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_1c22313e-2a44-45d8-bbfd-9be860e0300f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_SecurityExchangeName_1c22313e-2a44-45d8-bbfd-9be860e0300f" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_bf7a0a51-45d5-46b2-91c4-1b211f932086" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_EntityEmergingGrowthCompany_bf7a0a51-45d5-46b2-91c4-1b211f932086" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_9928033a-f04a-40d6-8706-06addad7dd5d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_EntityCentralIndexKey_9928033a-f04a-40d6-8706-06addad7dd5d" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_307eb949-61da-4249-962c-28cd3f78f099" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_AmendmentFlag_307eb949-61da-4249-962c-28cd3f78f099" xlink:type="arc" order="22"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>agl-20241204_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:17fb4859-5918-4cfb-84e0-0b572b54c452,g:8a35e750-400b-4819-bea7-8c5b4698656a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_21c2d98c-0ec6-4846-8faa-7927c73a09d2_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_995f45ba-7e65-4a2e-9b78-60b30a559b65_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_3deb8cb7-4a9c-4cba-b4b1-cc714df1149e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_2f4fe6be-37f4-4f68-895d-7b62cf81c285_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_511a79f5-48e5-424d-952b-cdb48413c59c_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_b3a3b039-be6d-4591-b8b1-3c2e8b7a1e8e_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_f73146aa-b40b-40a6-9a36-6bf4a2aaad75_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_f4521939-6c1c-4518-8905-9af754691f83_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AddressTypeDomain_4bb12ae5-fb17-4bbd-b31e-f8e9b1e1b08e_terseLabel_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:label id="lab_dei_AddressTypeDomain_label_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AddressTypeDomain" xlink:to="lab_dei_AddressTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_59459f8f-d2f4-4ec6-aea9-59c9e312a9bd_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_68d43576-0893-41fc-9150-53eb14c011cf_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_5860e5f0-ccd7-4029-ab39-9c2744b3ca20_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_045a332a-ffaf-4cda-944f-664d63daa3da_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_5a4ee3d3-39d3-4072-bac9-531b8a9278a7_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_c7edab20-76aa-4308-92d1-657167286f79_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_ff8f8381-1750-4959-8651-7ee42b3d5a8f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_54f1d535-d77d-4227-a740-7ccb1e7f4067_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_9027188b-d0f0-47b6-b978-4832100f9206_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_8fa7a492-7936-4ddc-8ea6-ab279faaf39f_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_6b166004-5b65-4511-96d3-25c839dbfe81_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_15de87bc-558a-4c1b-a9a3-7293d7f006fb_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_5de6dd89-ed74-4531-be36-2e01fb132808_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_4b1ffce1-5581-4e21-b63a-01e21e800b6a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_511d65e1-5425-4d88-9702-12fdfb1e4e9f_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_98629f54-1310-4bcf-9e99-d962eccd8367_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_FormerAddressMember_27f3b8cc-bd11-48a0-965a-c140e06ad9a0_terseLabel_en-US" xlink:label="lab_dei_FormerAddressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Former Address</link:label>
    <link:label id="lab_dei_FormerAddressMember_label_en-US" xlink:label="lab_dei_FormerAddressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Former Address [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_FormerAddressMember" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_FormerAddressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_FormerAddressMember" xlink:to="lab_dei_FormerAddressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_f8cd2bbc-6376-4dc2-be4c-1836e1308fae_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_a26c43a0-6eb3-446b-9628-541e856b928d_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_dedade3e-36a5-4733-a279-58b792c60afd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_label_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesAddressTypeAxis" xlink:to="lab_dei_EntityAddressesAddressTypeAxis" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>agl-20241204_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:17fb4859-5918-4cfb-84e0-0b572b54c452,g:8a35e750-400b-4819-bea7-8c5b4698656a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://agilonhealth.com/role/Cover" xlink:type="simple" xlink:href="agl-20241204.xsd#Cover"/>
  <link:presentationLink xlink:role="http://agilonhealth.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_b5360f0b-e2ed-4cbe-a73b-fa55f22f9e3c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_830efde0-3e01-4728-b71c-0682e5ce7aeb" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b5360f0b-e2ed-4cbe-a73b-fa55f22f9e3c" xlink:to="loc_dei_DocumentInformationTable_830efde0-3e01-4728-b71c-0682e5ce7aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_120e6e95-e588-49e6-84f9-7d6c66e8be7a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_830efde0-3e01-4728-b71c-0682e5ce7aeb" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_120e6e95-e588-49e6-84f9-7d6c66e8be7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_e681181b-9b38-477e-837d-499d8140a453" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_120e6e95-e588-49e6-84f9-7d6c66e8be7a" xlink:to="loc_dei_AddressTypeDomain_e681181b-9b38-477e-837d-499d8140a453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_FormerAddressMember_2f1e6590-d85c-4a51-863b-690108bf1c0a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_FormerAddressMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AddressTypeDomain_e681181b-9b38-477e-837d-499d8140a453" xlink:to="loc_dei_FormerAddressMember_2f1e6590-d85c-4a51-863b-690108bf1c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_830efde0-3e01-4728-b71c-0682e5ce7aeb" xlink:to="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_dedb13dd-590f-4f23-aad8-5fe4272e8a5c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_DocumentType_dedb13dd-590f-4f23-aad8-5fe4272e8a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_74860fe5-185f-451b-8fc7-165392898a79" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_DocumentPeriodEndDate_74860fe5-185f-451b-8fc7-165392898a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_59aa65f5-0f2a-4d14-a0e9-91f65b791254" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_EntityRegistrantName_59aa65f5-0f2a-4d14-a0e9-91f65b791254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_60c799b5-c513-4481-a5fc-e932921c5bd8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_EntityIncorporationStateCountryCode_60c799b5-c513-4481-a5fc-e932921c5bd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_693cfacb-09a6-4e0d-bdad-f1c06efe89fc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_EntityFileNumber_693cfacb-09a6-4e0d-bdad-f1c06efe89fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_e1e0ce93-de1f-405c-bcc4-1a38ea2090f4" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_EntityTaxIdentificationNumber_e1e0ce93-de1f-405c-bcc4-1a38ea2090f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_496aff1b-0e41-4618-b7fc-6350e18a8908" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_EntityAddressAddressLine1_496aff1b-0e41-4618-b7fc-6350e18a8908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_93b4d9a9-8435-4e7d-a44c-e4e5131b0a71" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_EntityAddressAddressLine2_93b4d9a9-8435-4e7d-a44c-e4e5131b0a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_6e7bedc1-938d-4955-91ec-f8cef4dfebf5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_EntityAddressCityOrTown_6e7bedc1-938d-4955-91ec-f8cef4dfebf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_9443fe68-7f1c-4fef-b899-40236ebb6aee" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_EntityAddressStateOrProvince_9443fe68-7f1c-4fef-b899-40236ebb6aee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_9af06eeb-83ad-4a47-bbb8-984290c3bdc5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_EntityAddressPostalZipCode_9af06eeb-83ad-4a47-bbb8-984290c3bdc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_4fff7fb6-3caa-48d4-8d9f-ecb6fd840f70" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_CityAreaCode_4fff7fb6-3caa-48d4-8d9f-ecb6fd840f70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_82ad377e-d231-43c8-8090-d605f49a63c1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_LocalPhoneNumber_82ad377e-d231-43c8-8090-d605f49a63c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_68ca1b14-f487-4939-a0c9-10625e260914" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_WrittenCommunications_68ca1b14-f487-4939-a0c9-10625e260914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_ca9b86bb-7d9d-4bb5-9d0e-d3ee4f77266f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_SolicitingMaterial_ca9b86bb-7d9d-4bb5-9d0e-d3ee4f77266f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_098963de-63a1-4c7f-9e81-ccdd8d7ec79c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_PreCommencementTenderOffer_098963de-63a1-4c7f-9e81-ccdd8d7ec79c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_4e252e2d-6210-4849-9489-21b660216b07" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_4e252e2d-6210-4849-9489-21b660216b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_565a3033-6f1d-4006-b7c9-b3ee1b2624da" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_Security12bTitle_565a3033-6f1d-4006-b7c9-b3ee1b2624da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_262e6818-9397-4ed9-a1e3-6901f0288a03" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_TradingSymbol_262e6818-9397-4ed9-a1e3-6901f0288a03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_1c22313e-2a44-45d8-bbfd-9be860e0300f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_SecurityExchangeName_1c22313e-2a44-45d8-bbfd-9be860e0300f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_bf7a0a51-45d5-46b2-91c4-1b211f932086" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_EntityEmergingGrowthCompany_bf7a0a51-45d5-46b2-91c4-1b211f932086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_9928033a-f04a-40d6-8706-06addad7dd5d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_EntityCentralIndexKey_9928033a-f04a-40d6-8706-06addad7dd5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_307eb949-61da-4249-962c-28cd3f78f099" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1b7a920a-2e12-48bb-aae1-ee42cc549819" xlink:to="loc_dei_AmendmentFlag_307eb949-61da-4249-962c-28cd3f78f099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45671211732592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Dec. 04, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec.  04,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">agilon health, inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40332<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">37-1915147<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">440 Polaris Parkway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 550<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Westerville<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">OH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">43082<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">562<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">256-3800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AGL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001831097<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_FormerAddressMember', window );">Former Address</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6210 E. Hwy 290<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Austin<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">78723<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_FormerAddressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_FormerAddressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MJN^NT9S_AJ&5-<)[WY;@B+Z[1K'3[5"OBJWYYE6;?6WYA=DBH$G$ER#DG'7
MQ=3N3>#NQ,@T?_NVD,;(.#]<<P:MB;T!?E]*:5Y/[ N]XGWLX&]02P,$%
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M$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA]) 1-MC0[!:+#Y
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M4')O<',O8V]R92YX;6Q02P$"% ,4    " !'@(59F5R<(Q &  "<)P  $P
M            @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (
M $> A5EV;E9(Y00  )L5   8              " @0T(  !X;"]W;W)K<VAE
M971S+W-H965T,2YX;6Q02P$"% ,4    " !'@(59GZ ;\+$"  #B#   #0
M            @ $H#0  >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( $> A5F7
MBKL<P    !,"   +              "  000  !?<F5L<R\N<F5L<U!+ 0(4
M Q0    ( $> A5FJQ"(6,P$  "("   /              "  >T0  !X;"]W
M;W)K8F]O:RYX;6Q02P$"% ,4    " !'@(59)!Z;HJT   #X 0  &@
M        @ %-$@  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M    " !'@(5999!YDAD!  #/ P  $P              @ $R$P  6T-O;G1E
C;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  !\%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="agl-20241204.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agilonhealth.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="agl-20241204.htm">agl-20241204.htm</File>
    <File>agl-20241204.xsd</File>
    <File>agl-20241204_def.xml</File>
    <File>agl-20241204_lab.xml</File>
    <File>agl-20241204_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="28">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "agl-20241204.htm": {
   "nsprefix": "agl",
   "nsuri": "http://agilonhealth.com/20241204",
   "dts": {
    "inline": {
     "local": [
      "agl-20241204.htm"
     ]
    },
    "schema": {
     "local": [
      "agl-20241204.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "agl-20241204_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "agl-20241204_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "agl-20241204_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 29,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 28
   },
   "report": {
    "R1": {
     "role": "http://agilonhealth.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "agl-20241204.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "agl-20241204.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://agilonhealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Address Type [Domain]",
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://agilonhealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://agilonhealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://agilonhealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Line Items]",
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://agilonhealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Table]",
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://agilonhealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://agilonhealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://agilonhealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://agilonhealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://agilonhealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://agilonhealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://agilonhealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://agilonhealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Addresses, Address Type [Axis]",
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://agilonhealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://agilonhealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://agilonhealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://agilonhealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://agilonhealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://agilonhealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://agilonhealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Former Address",
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://agilonhealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://agilonhealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://agilonhealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://agilonhealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://agilonhealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://agilonhealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://agilonhealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://agilonhealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001628280-24-050056-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-24-050056-xbrl.zip
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M,2?7#1[ST( 46A,\(KZ*/AC4R'_[\KGE]%B?:HO8X)#N H2D6RFO&J=\B34
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MG)3/W,<=+UNS<JL6_[U)/#!.<V8X]Z09-RQ7,T_:I]O)O_KVIP:\N08THVC
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MGJZZ061WA3["FVGVI)SF02CG3Q5\O@J:+Z&"-TD^_Z<&OK4&6OM7P'T07@\
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M/   %    &%G;"TR,#(T,3(P-%]D968N>&ULW9O;<MLX$H;O\Q1:[^W"PIF
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MCF]]71Q7]7S**173;>NC3?/;O?8WHFO-K+73[M,O35=Y7T/LEDW_?/_N4UC
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MPCQU&7L2UOR 6?^<6_=99Z.Q/L67'^J+ZJ:<:<@\Q,"(%::M "B%B2,$DDR
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MX6F<C9V<V>AYR55#;58M!?+BJ=M<^;K]0=K2V:VM+HUZ>95_G[A(DVH!5CT
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M0KH=%U<H)41B)5#<%[!NF1-CYH2!VE*.5M)1K=V?MCUI.LS<<<S[D1?FVPO
MP[:",-P3=C08#UO;1K+'Z-":]VYNBBM70O]=Y'?EM5.Y$8N':4P2@3$2P%IA
M 5%: $Z(!9023;$6POWG5_I:=<:I@!OI:*4=K<5]*V%[IOH6Q,'^@^JBK_6
M^KC7V( RV1YWY&JYU]QNT=P_/!31<X=\(687#OK[_YB':2*(,5AC@+G[0>(4
M 2F4V[%A*)G@*&4B]8/SB<(X6*Y%HUHU<K*^0#[-2U\4![@-@K"_T0#\.LP,
M .]IQ)&1ZS"T"UO7P%#,WF<SL^YEJ]1H(5$,TNH<&<$Q QQI"&B20IHB1FW*
M_0C[$7P<N"J]P ;_5A[Z$A7F+@BF/L8",-IU,("@K6 CP[-K8Y>;EC$#+YJM
MKW/_5'PN\N^9F^C46F899A# ^MN2/.& T02"U!B")-:)8)Z-DW:A<5!ZO)KT
M\0L6&_W :VB?IJLO9<.3$$1<@/_P2VH[S V_KO9IX.>YN+;#7N<5MEWC![=A
M+I;+6U,TFC'$0IW@!.@TU8 @E *1$E<"E9+0I);$M/>J\I#8V"V9U02.TYG9
MS9QW?V90/@9V:7Q2,:19T^GQ&"V;W>#/U;CIM+FG?=/]FH%U>/W/AVQAX)3'
M*(6,2:!CZXIP*BF0/&6 ,(Q@'%N.8AI4A+=51J[ F]/)E7;T:1%:@!MY\JR^
MH>Z'E=[>QL,K;YNQX66W$?5Y:FZ;L<Z"VSK8'\O-/4HN%M5]2.KK7JJ0%Z69
M+Z?,BE00CD#*,05$:P68$12X'6?*K1 6\][+XWU")X;S\3XL6]K1M_H(K>4]
MKF+9FZ[#@!XK"7Z,AOOW@K2/N2!.]P8>#=4^]K9I[37^*,!>"CDS4RHAI7%,
M0"*K[U@G$ ).-08H40QS+:UA< "LM<BS@%HK#V-TE:$@/KU]'X/- Y:'8MGP
M="PD5T&?$\>&K0,H-L<.7,Y^SI>EF/TWNZF_P@(3;5@J%4@2)@!14 +!!08I
MXEBG-HZIE4'KV8;,R O:E7;DQ(/N8M*:*,\%;;#]82O:OL[#%[2MQH:O:)MA
MGV=)VVJM<TW;/MH?SC^*K"S-HMK*WB[65W,OIPY+JC7CP.B4N *)(9#&K6N1
MB:&5$",6L[Y<MBJ<&,FU9M04[4]B>U8.0SC8JQ]_GC:]L-MK)8BX]HBCP;;7
MT#9G^P<>KYV#ID1":Y6!5?F#@!CD,*-8@!BZAX;%L:2>5^2TJ#QG.^?R+A_>
MSD$#VCE>[H_8SMEG_"CM''2\XM>(^NSM''2P]+4.]L>RNE'J[/-UOMB<&'?;
M0$V3BD:"W*Y0,P9X&B, D=6NZ!EB^K=PG@8_,82U7%3K>5\@L).'P[0-<><'
MF8<Q+ZRZ' 31M!-L-(BZ;&RSTSDF_(9U$,G+K)R9*6<4<9L0 #&, 9'* FXX
M!YI39)32#/<_O_@T^(F1J36BW$80_4/^,]JH^]^I[C$9A[D98M&/&U]W0;>H
M>VICT.WI'H.-?FNZIS;:;DNW,\8?GO=Y,3?%NGC]9NJ/6I1:+)E20&KH%H!,
MQ(#31  %26QB*C07O;\LT1+_Q BM%#<+G_[DM&7B,#P#_?GQT[06?5OI':G-
MN,=)$$)M\4:C:(^9;9#V#0OO[#_>(?M749JI94HC*16@.*W.P2D$I"$*0%>&
M#,0QLZ+W5\9;%<;JZ:]$(Z<:5;+^_?QF7OHW\X/=!G;R^QH-ZN*WFAG4PF]&
M'+U_WVJHK7G?/C <L^H;ZE.!J"+852AJ) :$4.EJ%6)NMP0-2ZCDB/7^3OEV
MX+&@JK3\2:JM]P?(UU @-WN]!,&R/?%!C-2!1D=C>_IM1#3^/K"%9S8=B"KH
MV_MLZ89HH0TV %.1 ))B# 1*.4B83#E2-!:V-QK[I49MYIFMKM;J9A_5%#Q.
M+Q](FV=;;U RAO3V?/,0WN#KM#B\R[<;^GE:?9T6._M]W:_H GG[G?G@'KUY
ML7DF6_TOC=Z\^#]02P,$%     @ 1X"%6=>]1;+9!P  XSX  !0   !A9VPM
M,C R-#$R,#1?<')E+GAM;-6;VW+;.!*&[_,46N_MPL*90"K)5-9)MER33%R)
MIV9J;U@X-"16*-)%T;']]MND[4P<.UG&Y)3$&QTHD-WX\;'1:$+/?KG<E(O/
MT&R+NGI^P [IP0*J4,>B6CT_^/WT#3$'O[QX\N39/PCY\]\?WBY>U>%\ U6[
M.&K M1 7%T6[7K1K6/Q1-Y^*SVYQ4KHVU<V&D!?]:4?UV553K-;M@E,N;YO=
M_MH\95GRTBA+E&6&R) \,1(HH5YEW"L9I.+_6CTU3BC(%"624D^D899X<!DQ
M07FIK=%*7U^T+*I/3[L7[[:PP.Y5V_[K\X-UVYX]72XO+BX.+WU3'M;-:LDI
M%<O;U@<WS2_OM;\0?6MFK5WVOWYINBT>:HB79<L_W[W]&-:P<:2HMJVK0F=@
M6SS=]@??UL&UO>K_UZ_%=UMTW\AM,](=(HP3P0XOM_'@Q9/%XEJ.IB[A Z1%
M]_[[A^,O)MVJ*.MJ#:YLUX>AWBR[!LNC&H% 5_M3VZLS>'ZP+39G)=P>6S>0
MGA^X54FZ(66<RL[>/Z_/6_YE]JR!+;+2=_,M'K@YO3/R\R[ 90M5A.MNW5HH
MZW"G4=F)6G\YLW0>ROYH'J'(^ZN^]-NV<:'-O1*:)H0).$0$SP-QF? D.:42
MY\F""'=[W+F\19_[,=A".%S5GY=XX64G0_>AUZ/7XIZY:UT>Y_?M37=<=3=6
M+^>I\R7D1E!($6\6 901F7%#?,8"H=IP4 $R!WY4%[YG^6YOOA[GETU8U$V$
M!J/)K6G7A#MC?I_CFQ;+,]?@A4A8%V6\/3LU]6:*,6SKB16]'CIT_6"!"B1H
M&HAOKT?NNQWM>]EBO(6^Y1@J7E=MT5Z]C!'5W\+VYL,IGOGRLMCF>%N"!JL(
M*(-QU8+&N)HLR:(.6H/QV)=1;/S8_NX(F69LZ[]%Z!TC\Y7KK^J-*ZH<M&',
M,$^L%^A\E@$Q(L-;R=IHF*1.*C&*DGLF=P?&E.-83R7JCHEX@[<(QM/K+KR#
MC8<FYXF!5I:2:%0@TBE&C,:@JBUEU/C$ AT7.1XPNCLJ1@Y?/9V6.T;A@;B)
M21L<M[#!F\-GSG+J" =,,*7QGC@'C !('H*2%A/RJ3.-+]8'P<%G,9=,)O*>
MP-+=-G@@>B9BQ"4<340F+M#O:(A*Z'C&P3@U+I/^VMI>)1:/'+L'@/AI(?<$
M@!-HBCJ^KN(KUT*>28/Y."C"C,(.* RB)H6,,*V$Y<8:ETT3)NZ8W:OX,!T2
MCY=V+U8F'V!5=,NTJOW-;2!7UCFMDB(T<4=D9)(X"I98EK3RF65<R0G6(W>M
M#B)#S(:,T<+N!1C'5:B;L[KI1?F(PP%']7G5-E='=81<TY!9ZQ4)B@DBI6'$
MJ10(6,$M9T'Y:";@Y(=.#,)&S@R;Z63?"XK>%"7\=MXGV=J*D%SPA%JGB00:
MB8\NDBZ[UNB?L6E<_O&MQ4%\J)GQ\4A!]P*&4W=Y'%&6(A775?6;C@ #&A!A
M$H'AI$EQ#>9#D(0Y8<!QBFG6%)/.=\P/PD3/#),II-X+9FX6ZC=OG3PLEU:[
ME#"UHB!Q6:=9MZS#**B%HL",,Y9.,?D\8'H0*]G,6!DK\9YRPG,KO(S666*D
M4!@@LTB<E#A;2L#IDWGJ,O:W<,('<6)FS\G/2;Q/G!SAQ_?-:7U1Y1HR#S$P
M8H7IRH=*85(.@203(,F8P"<U'25_&1[$B)TG(X^4=Y\(Z7/O]\U)4W\NJ@"Y
ME5(DT(9DF%\1F2 1;ZS%.90+#=YK!S =)M]8'U9.H_.$98S2^T3,2;UM7?G?
MXJQ?JEF7, L'3XS G%PZF1'OO2'62&YI$#Z&"</*'=O#:)E/]74BE7?,2A<3
M7S;@>K]E2BE+7A,1G$,IHB0FVD0@>)VBD31E=!0=7UL;QL-\2J^/5G+'!'2;
MR<J3=5W=KN -=U%T3RXC%YAEBV"(H=UC2$U5DKBJ%V%<@OJMQ6$DS*?4.DK1
M'=/P1U.T+51']69S7MVLTK>Y-L$QSR1)TF28+@E+' V6,*JY JZI9>-J(0^:
M'<;%?&JIX[7=,1P?Z[((15M4JW>8'#6%*_/@K#<:%<BBQ:G.>TRD(T72!:J1
MLHQKG4:1<=_F,"SF4T(=J>J.F3AIH ,:,$?NGT5W&VV;]PG]R*DU5HL(1 N'
M82]DB5@PC(00HXD9A,R.JZU_W_8P1N93/YU(Y?UBY7B[/8?FZ[Y(X(H#CT1S
M1E$>:8F5QA+.O-:4,^UI-B4Q]SP8QLU\:JF3*K[KV0?".<Z@5XS[TZ(M(5=:
M.4&%(#JQV/VY0Q.?X<SI,4HRSS67<=QFPV\M#J-C/A7448KNF(;3QG7_-/IX
MM?%UF:-KW=9+7&(+BTD41$RB&(A^KV2BW!A'Q^U%OF-N& ?SJ9(^7LL]"0FO
M+\/:52OH-[6PP'&9)8!P)R61*AKB?8K$>C": A64CDQ)'[ Z;!_9?&JAHY7=
MBQKHZPTT*R3[/TU]T:YQ)CQSU57N4^9HMYT:>Z"(U)X3R[K'S9XSEJS@U.A1
M@/S ^#!.YE8%':_S7N!RA.HTKCS&].CR5[C*K>4&9T-'$I4.I\.HB<EP3J3:
MQ>AB%J.*$X#RC=EAB,RG,#I>VUW_]0DEB9TL;TJWR@7-P%O,DS6+Z#CO,F;-
M ^$F1)$RDZ@=MT_YCKEA,,RG-OIX+2>#X-GRGI;8KT\OGMS\T+UT_XE^\>1_
M4$L#!!0    ( $> A5F>%W60(4   %65 0 >    97@M,3 Q:6YD96UN:69I
M8V%T:6]N86=R964N:'1M[7UK<]O&FN;W_178I":1JF ?29;OF53YV,Z,=W.<
M4[:G\G&J231%Q"# @P8D<W[]OK>^ 0U*<N2(XFJV]L0B0:"[T?U>G_=Y?UIV
MJ^KGGY9:%3__KY_^]X,'V9MFWJ]TW67S5JM.%UEOROHL^[W0YG/VX(%<];I9
M;]KR;-EE)T<GI]GO3?NY/%?\?5=VE?[9WN>GO_'?/_V-'O+3K"DV/_]4E.=9
M6?S[=^7LZ9.3YX^?GSP_>C([G3_1SYZI1R>S$_WLZ.3XZ.3Y_+^/OX.?PN7\
M&]-M*OWOWZW*^L%2X_-?/'_^\-&3=??RHBRZY8OCHZ-_^RZZM--?N@>J*L_J
M%S1@^';1P/3DZWE3->V+[X_H_U[B-P\6:E56FQ<_?BI7VF3O]47VH5FI^L?<
MJ-H\,+HM%WRA*?]'OS@^@8?3GQ<\H*=PGZJLM1W@\0D.Z8?OCY\<O1S_[]LO
MRW)6=MGQT</CG_Z&]PFFRT.%-6M_CK\;+XAJSV!-9DW7-:L7Q\]@3,'$Y_ >
M='LK,^=A%'K>M*HKF_I%7Q>ZQ:N^^_G=^S=O__'^W2_O7K_Z].ZW]]FK__CP
M]NT_WK[_E(U68F*>)_$\_^A-5RXV_%$)#ZJ[%[@YOOG,3Y/O_-.R--D[&,:J
M+A?EG.:?O3IKM:8#=O##]\].3HY>ND_H[^.7AQG\;*4*G2F3-8OLOZ/_R_G$
MS3:9JHMLIKL+K>M,G945W!R.6-4M\ZRLYP_S3&5O=*4N5*LS6/ZUO('LH%OJ
M3)[]NEFM5;VQ3\[IIC]\__SXY=\;U1;9F[+5\ZYIL_=JI>'S1R]QV(].7\JT
M.JWIS\.'64;3]=,S_5JW1H/<H)NV>EVI.?W!0U=5E:U;?5XV?? SXZ:$HY3A
MT?7^B3";<W@C()7P&M//_H QPHIUL,EQP;IH(#"R*^^GW3DWW_W\X>WK=Y]>
M_?IQ/\["[__Y]L/;5Q_S3*OY,GL%+Z8 W8+O]8,V'2F:U[KM^)QH?(OOZG#3
MTFOU&R+:PUM^YXX4/@E_DWSRWS=P3,RV9_ 5<C<^)5USIN&*-KLHNR7_<,M
M\BP<\5*UL+'<X%K]KQX.6E8.9(4,J)!#.!SAPZMO[#NR.8(SOE)P["O3@#S(
M8'AH0^":C]9HW;>F5S!F^ [7YC]TK5M5P1KYS?.KNK!+][&3M^-$8_B:W_S'
MZU_M6R&)!FO-[\IM(+PDTU] <AE3;4""-><EB.INJ3KZ?C0^O,# OTQF=)<M
MFI9W2ZM+$-OP_+KIX'[S"NRL<YW;Y[0:)/P<5DZO0&YV\@#\H%7SSM#R\,K
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MR!O@BGR.3EV/2]7.5*W-@]^^5'ICN_"<'!V=9 ?XO6VP,+I,HBJ'SIVVULF
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M6_+/N4YPS^3C\[LD'__1%''$]'<%RJV]Y3C^^R8X%7FV"@>)N\LBQ;<YOBY
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M6U2P1OXX_5I<V*7[V,E^.9D9;OR;_WC]J]TGDG&PUKQ[[DCA1V!+0)894VU
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M#7X^J(6FW^*IPAK=MHO*I-MFH0P6>!=HJH'U7"/2B%\(#SY7E:OL!4NNI^J
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MF54[S$42*YT#_1=IRQ%E$%>[W&:IC5N7+5N?2<!)%95L/@%^"1Z+02ZWSGD
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MG5HDB.S%@NU*.H(H(C0$ON)6RE HV#2>/=P6_KJ[+1.ZPN46Q,;0[70G#:[
M?UG0>ME3A>Q*!?!'W _B^*:V\7%/HG:FNW9+#N447Y,0E%L].@P.4K_!4H)]
MTHQ(QK+H6UI[YALS6M THR;L!W!3_Y EEB-@,S544 26IK$ETXHN=%&Y9G?P
M!6P#IS (B84W^Q+5V3TDPKL8*H2"KB<&NI!2-ZQ=F([$Z0#UPYH)CCX_KW1/
M<\>,B'-\]<)29://VM0^@A1**?X?2#=I=4Q?W#L$P.YTT+T2 D"9?K46^0G[
M^G:Q$,3(:V&"2_72O<_!WSA\WZ8TBDNR6Y=$:QUH)[)KF_;Z.90IVO^)TLXU
MG:11+]3+\*9)%KB8YW=)EL),"!:W(AZS1.O&")NPS0$9 "^O-7M&HBZQ25);
MJEI4)#.*8_.!>6.79NUO7*JT%9\A&R-4DM-),)&F\=ZY.EX:?_Q"+/\*#-8%
MZ.F@R,'GR#R3QR;F.; VYL ,.73MU]GC&0S)E9)RG?'84I(ZQE'5W(C\<J2Z
MQ+&SC7RC5GPSQ8UZ!T=I)5YMPK3!\8@Q@^Y!*S66Z&3&,QIE%;]BQ1+P6_:Z
MQ?^Z;'Q.)Q>NVYDUVN8VY3PG7FQR@/VIV_;FRQ=F7XRZ'4S5??2V=^ ,J,-<
MT"Y;1(%:$=4%.SW.$8N<F.PX$7Y)5Q!<77P/<FW)ZR]Q J._H(/Q) X33)>S
MV\@31\$Q+=Z(4J-XE,&&G=?-97Z-:(^:,PT\\$'\_#Y_=A?R9\_O\V=[DS]S
M2C 44J0^Q[4P' PF8M$,HY&.+",1DL32^Q9C-QADSIDEQ)<XC3\20ZJ(PC@!
MEO>O)'TK#P!'&AY<J8+#DA-&X=8Z'PLC+9P "VNUTC;WL$<!IJ1L\B=HON,#
MPD^.'I04S 1SKK0I!Y*=B-0@0H<0$\=T(CA1]%J^H ])]I0GR1^RG%Q!SXEI
M/,:Q7---BAM\2X+#6'84/T*D1K'A4"[FE2B>.B^JOK"UU*-2/QM*#3%_+.QM
MD2ZU>F#49K#L$J?+?;H&OJ_.FJA!P+B5X?$C))@=TBT(^/E&0#\C!.HTXF=L
M9% )XR*9U$,*0LY0/1"9H9[@_WLI/YW,'C]]7GQ+0_ VLWFO#JUUM- @S"F)
M_?@K["-JJS7VXWW='Q?W25R<1"25EJ>^TXSW6FZ IGX7!DZJA*^1\A./>XT>
M$J8+W>EFSW>&]9A5Z2Q RO-O'BP08'#P]/$X6V]GZYB2XK%IH7ZF5Q0LEQ&E
M7C#V/Q@$L2D',X!OSN%RJ/*R]8Z&X=J$<;,8?.IDT"3GW]D!:,-3=SMCG['5
M&@;SDIQ(RCLU=LC760U]@W?^>D"_,2',GGB*NQ?^1V1PHD-MW 5]>]O:SK8^
MGVV"0L.FI<AA4)[(/6[.]=P9&H1]!T,##!9\QVXB-6H8P:V6J^WFLE"[(OQ1
MW>KB"'TJ6EU@1M')\[;+@>>4]:40Z@M&L$RU&4.#G;PA$03/514QGX'81Z!'
MP0D-TI:6%RU.DR?(;*X4-RLUXP'0_(_M2>9Z(!\!#/EV7'P;U&+,;*;6%N#B
M^PEFL$9]X=KHSE#/V\JE4;\"#(VD@/_S5J\("Q$"'\8!P#(TW#EJ2L.QE S1
MYW\T+N.+W7?[&MR'15_MB[@O=TG<'R4;UHVC_O!+?_[278<'0:QB+I2XP;G5
MR=:$A4,!"6>]M$)$"5.2<S9KFL\\,*9\=U3<>%S7R#H<EHX@.*<F:\VS"^92
M(13Z2T@O6.E1R=S,YIV#"+ME7QZ_V*4&&JQ,DK^#(5OVR-EN7TMA[_)<$**5
M.B-4 UL\U@@,GCD>*X%X>#T(12HMOYK6=BN16QP\A-([)'RLC86]M[CT?MW/
MP#>WRUG4%D6#UO9Z3<3+;1XL).%Q&\]Y0EP0B*JQD6"1#<$=;U6J+BL>HQ0A
M;7<\R]#Q'':R5]S!ZEP)?);8"BQ)](40+/*0X^2-0S-;K%P IQH?YJNE+@)(
MX4AY[$MJ6^V2]'+&ZN>ZN0!/YDR%L1&6*WP';2H2U18%W$3(R25W_.J@O%I8
M<41?(R"TQM_ J(LS%"PKM9KQO8#=UD6+N/$S,6(M*WM"0D2G5Z\8S1++G,5
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M"7(=FR (XZ,O7G#&Q>BHX[EE*]*O8'\@\?9#O-L FD,6YY^NIA][-Y'O/I<
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M+3(P,C0Q,C T+GAS9%!+ 0(4 Q0    ( $> A5D*-"'D'P@  "$\   4
M          "  2 4  !A9VPM,C R-#$R,#1?9&5F+GAM;%!+ 0(4 Q0    (
M $> A5D:<)O^, P  *)J   4              "  7$<  !A9VPM,C R-#$R
M,#1?;&%B+GAM;%!+ 0(4 Q0    ( $> A5G7O46RV0<  .,^   4
M      "  =,H  !A9VPM,C R-#$R,#1?<')E+GAM;%!+ 0(4 Q0    ( $>
MA5F>%W60(4   %65 0 >              "  =XP  !E>"TQ,#%I;F1E;6YI
M9FEC871I;VYA9W)E92YH=&U02P$"% ,4    " !'@(59\9*+<EA   #TDP$
M'@              @ $[<0  97@M,3 R:6YD96UN:69I8V%T:6]N86=R964N
9:'1M4$L%!@     '  < V@$  ,^Q      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>agl-20241204_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="agl-20241204.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001831097</identifier>
        </entity>
        <period>
            <startDate>2024-12-04</startDate>
            <endDate>2024-12-04</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001831097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:FormerAddressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-04</startDate>
            <endDate>2024-12-04</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-27">0001831097</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-28">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2024-12-04</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">agilon health, inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-40332</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">37-1915147</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">440 Polaris Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-8">Suite 550</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-9">Westerville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-10">OH</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-11">43082</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-12">562</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-13">256-3800</dei:LocalPhoneNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-2" id="f-14">6210 E. Hwy 290</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-2" id="f-15">Suite 450</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-2" id="f-16">Austin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-2" id="f-17">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-2" id="f-18">78723</dei:EntityAddressPostalZipCode>
    <dei:WrittenCommunications contextRef="c-1" id="f-19">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-20">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-21">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-22">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-23">Common stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-24">AGL</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-25">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-26">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
